WO2020001494A1 - Diarylethene compound and preparation and use thereof - Google Patents

Diarylethene compound and preparation and use thereof Download PDF

Info

Publication number
WO2020001494A1
WO2020001494A1 PCT/CN2019/093093 CN2019093093W WO2020001494A1 WO 2020001494 A1 WO2020001494 A1 WO 2020001494A1 CN 2019093093 W CN2019093093 W CN 2019093093W WO 2020001494 A1 WO2020001494 A1 WO 2020001494A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
substituted
unsubstituted
group
alkyl
Prior art date
Application number
PCT/CN2019/093093
Other languages
French (fr)
Chinese (zh)
Inventor
邵旭升
李忠
侯晴晴
须志平
徐晓勇
程家高
Original Assignee
华东理工大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 华东理工大学 filed Critical 华东理工大学
Publication of WO2020001494A1 publication Critical patent/WO2020001494A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles

Definitions

  • the invention belongs to the fields of pesticides and medicine. Specifically, the present invention relates to a photochromic diaryl vinyl compound, and a preparation method and application thereof.
  • Photoisomers can also be called photochromic compounds or light-controlled switches. There are two types of isomers in these compounds. They show different physical and chemical properties in terms of absorption spectrum, spatial geometry, and dipole moment. . Under different wavelengths of light, compounds can convert between two isomers and this conversion is reversible; they have different absorption spectra and can produce reversible color changes. So far, there have been many studies on photo-isomer materials, and these compounds have been widely used in optical information storage, liquid crystal materials, molecular switches, and biology. Due to the excellent photophysical and chemical properties of photoisomers, many new photoisomers are also being developed.
  • diarylethylene plays a very important role.
  • Heterocyclic substituted diarylethylene compounds have a hexatriene parent structure that conjugates six electrons, and its photochromism is based on an intramolecular cyclization reaction (pericyclic reaction).
  • pericyclic reaction Under the excitation of ultraviolet light, the compound spins in a closed loop to form a chromophore.
  • the chromophore can undergo opposite changes under visible light irradiation, and a thermal irreversible photochromic reaction occurs.
  • the compound generally exhibits good thermal stability and fatigue resistance. It has received great attention from people.
  • This structure has attracted much attention as the core unit of photochromic generation. It has become a hotspot to obtain new functional compounds through the optimization of its structure, so the synthesis and modification of this structure have also been repeatedly innovated and attracted much attention recently.
  • diarylvinyl compounds are ideal photochromic materials due to their excellent thermal stability, excellent fatigue resistance, fast response rate, high conversion and quantum yield, and excellent solid-phase reactivity. one.
  • diarylvinyl compounds can change the end-to-end distance of the two ends of the molecule through photoisomerization, thereby causing the functional changes of the target biomolecules. If the target biomolecules are opened or closed, the target biomolecules can be completely Inactive or active states, diarylethylene optical switches will probably be the most effective. In a stable dark environment, diarylethylene compounds exist in a more stable ring-opening configuration. Irradiation with ultraviolet light can transform into a large number of closed-loop structures, and closed-loop structures can be transformed into open-loop structures under heat or blue light. Diaryl dilute compounds have been used in light-controlled coupling isomerization reactions, including peptides, proteins, and nucleic acids in vitro and ion channels and receptors in vivo.
  • GABA ⁇ -aminobutyric acid receptors
  • GABA ⁇ -aminobutyric acid receptors
  • GABA receptors are widely present in the central nervous system of vertebrates and insects, and can be regulated by the neurotransmitter ⁇ -aminobutyric acid and some exogenous drugs.
  • Many human mental illnesses such as epilepsy, schizophrenia, insomnia, alcoholism, and Parkinson's syndrome are all related to GABA receptors.
  • One of the objectives of the present invention is to provide a class of photoisomer compounds that can be used as GABA receptor ligands and a method for preparing the same.
  • Another object of the present invention is to provide applications of the above compounds in controlling pests and the like.
  • a first aspect of the present invention provides a compound having a structure represented by formula (A), or an optical isomer, cis-trans isomer of the compound, or a salt thereof:
  • R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
  • Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
  • R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
  • Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy
  • Z is selected from S, O or NH
  • the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group.
  • R 1 and R 2 are each independently hydrogen or C 1-4 alkyl.
  • R 1 and R 2 are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or tert-butyl.
  • each R 3 is independently a hydrogen, a C 1-3 alkyl group or a halogen atom.
  • each R 3 is independently hydrogen.
  • R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine or C 1-4 alkyl;
  • R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen or fluorine.
  • each R 10 is independently a C 1-2 alkyl group or a C 1-2 alkoxy group.
  • each R 10 is independently a methyl group.
  • Z is S.
  • a second aspect of the present invention provides a compound having a structure represented by formula (B), or an optical isomer, cis-trans isomer of the compound, or a salt thereof:
  • R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
  • Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
  • R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
  • Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy
  • Z is selected from S, O or NH
  • the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group.
  • a third aspect of the present invention provides a pesticide composition comprising 0.001-99.99% by weight of the component (a) and the component (b); wherein,
  • Component (a) is a compound according to the first aspect, or an optical isomer, a cis-trans isomer, or a salt thereof; and / or a compound according to the second aspect, or an optical isomer of the compound Structure, cis-trans isomer or salt thereof;
  • Ingredient (b) is a pesticidely acceptable carrier and / or excipient.
  • the component (a) accounts for 0.01-99.9% by weight, and preferably 0.05-90% by weight of the pesticide composition.
  • the insecticide composition is used to kill or prevent a pest selected from the group consisting of Coleoptera, Lepidoptera, Hemiptera, Orthoptera, Isoptera, or Diptera insects.
  • the pest is preferably an Isoptera or Lepidoptera insect.
  • the pest has a mouth suction or file suction mouthpiece.
  • the pests are aphids, maggots, planthoppers, whitefly, leafhoppers, thrips, cotton bollworm, cabbage worm, diamondback moth, Spodoptera litura, and armyworm.
  • the insecticide further comprises other active substances selected from the group consisting of: insecticides, baits, fungicides, acaricides, nematicides, fungicides, or growth control Agents, and application of the pesticide composition to pests that endanger animal health.
  • a fourth aspect of the present invention provides an insecticidal and / or pest control method, which comprises applying one or more of the following to a plant body that has suffered or is likely to suffer from pests, the surrounding soil, or the environment:
  • the compound of the first aspect or an optical isomer, cis-trans isomer of the compound, or a salt thereof;
  • the plant body, the surrounding soil, or the environment is optionally illuminated with light having a wavelength of 310-380 nm.
  • a fifth aspect of the present invention provides the compound according to the first aspect, or the optical isomer, cis-trans isomer, or a salt thereof; the compound according to the second aspect, or the optical isomerization of the compound Or a cis-trans isomer or a salt thereof; or the use of the insecticide composition according to the third aspect in the preparation of an insecticide composition.
  • a sixth aspect of the present invention provides the compound of the first aspect, or the use of an optical isomer, cis-trans isomer, or a salt of the compound, the compound, or the optical isomer, cis,
  • the trans isomer or a salt thereof generates a compound according to the second aspect, or an optical isomer, a cis-trans isomer, or a salt thereof, after irradiation with light having a wavelength of 310-380 nm;
  • R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
  • Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
  • R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
  • Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy
  • Z is selected from S, O or NH
  • the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group.
  • a seventh aspect of the present invention provides the compound described in the second aspect, or the use of an optical isomer, cis-trans isomer, or a salt of the compound, the compound, or the optical isomer of the compound 1.
  • the cis-trans isomer or salt thereof generates a compound described in the first aspect, or an optical isomer, cis-trans isomer or salt thereof, under light having a wavelength of more than 493 nm (preferably 493-760 nm). ;
  • R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
  • Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
  • R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
  • Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy
  • Z is selected from S, O or NH
  • the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group.
  • An eighth aspect of the present invention provides a method for preparing a compound according to the first aspect, or an optical isomer, a cis-trans isomer, or a salt thereof,
  • the method includes the step of: reacting a compound of formula (1g) with a compound of formula 01 or 01 'in an inert solvent to obtain a compound of formula (A);
  • the method includes the steps of: reacting a compound of formula (1g) with a compound of formula 01 in an inert solvent to obtain a compound of formula (1h); and in an inert solvent, (1h) reacting a compound with a compound of formula 01 'to obtain a compound of formula (A);
  • the method includes the step of: reacting a compound of formula (1g) with a compound of formula 01 and a compound of formula 01 'in an inert solvent to obtain a compound of formula (A);
  • the method for preparing the compound of formula (1g) includes steps:
  • the method for preparing the compound of formula (1g) includes steps:
  • FIG. 1 is an absorption spectrum chart of the compound 1 of the invention before and after irradiation with ultraviolet light in an acetonitrile solution.
  • Figure 2 shows the fatigue resistance of Compound 1 of the invention at specific wavelengths.
  • C 1-4 alkyl refers to a straight or branched chain alkyl group having 1-4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl , Sec-butyl, tert-butyl, or similar groups.
  • C 1-4 alkoxy refers to a straight or branched chain alkoxy group having 1-4 carbon atoms, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, Isobutoxy, sec-butoxy, t-butoxy, or similar groups.
  • C 2-6 alkenyl refers to a straight or branched chain alkenyl group having 2 to 6 carbon atoms, such as vinyl, propenyl, isopropenyl, butenyl, isobutenyl, sec-butyl Alkenyl, or similar.
  • C 2-6 alkynyl refers to a straight or branched chain alkynyl group having 2 to 6 carbon atoms, such as ethynyl, propynyl, isopropynyl, butynyl, isobutynyl Group, sec-butynyl, or similar group.
  • halogen atom refers to fluorine, chlorine, bromine, or iodine.
  • halo refers to a group substituted with one or more of the above-mentioned halogen atoms, such as trifluoromethyl, pentafluoroethyl, or similar groups.
  • heterocyclic means that at least one of the atoms forming the heterocyclic skeleton is not carbon and is nitrogen, oxygen or sulfur.
  • heterocycles contain no more than 4 nitrogens, no more than 2 oxygens, and / or no more than 2 sulfurs.
  • heterocycles can be saturated, partially unsaturated, or fully unsaturated rings. For example, pyridyl, thiazolyl, triazolyl, pyrimidinyl, dihydrofuryl, tetrahydrofuryl, oxazolyl, piperidinyl, piperazinyl, pyrrolyl, morpholinyl, indolyl, and the like.
  • 5- to 6-membered heterocyclic ring refers to a saturated, partially unsaturated or fully unsaturated heterocyclic ring having 5-6 ring atoms, such as pyridyl, thiazolyl, triazolyl, pyrimidinyl, dihydro Furyl, tetrahydrofuryl, oxazolyl, piperidinyl, piperazinyl, pyrrolyl, morpholinyl, and the like.
  • 5- to 6-membered aromatic heterocyclic group refers to a completely unsaturated heterocyclic ring having 5 to 6 ring atoms, such as pyridyl, thiazolyl, pyrimidinyl, or oxazolyl, and the like.
  • 6- to 10-membered aromatic ring group refers to an aryl group having 6 to 10 carbon atoms, such as phenyl, naphthyl, and the like.
  • photochromic refers to a compound (A), which can undergo a specific chemical reaction or physical effect when receiving a certain wavelength of light, to obtain the product (B), which is caused by the structural change (the visible part of the A significant change in the absorption spectrum occurred. Under the action of light of another wavelength or heat, the product (B) can return to its original form.
  • ring-closing product refers to a compound obtained after a diarylethene compound is irradiated with ultraviolet light of a specific wavelength, and a ring closure reaction occurs in the molecule.
  • fatigue resistance refers to an evaluation index based on the number of cycles between the coloration and decolorization of a compound undergoing photochromism.
  • inert solvent refers to a variety of solvents that do not react with the starting materials, including various linear, branched or cyclic alcohols, ethers or ketones, haloalkanes, 1,4-dioxane, acetonitrile, tetrahydrofuran , N, N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), etc.
  • composition refers to any mixture. It can be a solution, a mixture, a liquid, a powder, an ointment, an aqueous, a non-aqueous, or any combination thereof.
  • the compounds of the invention may contain one or more asymmetric centers and therefore appear as racemates, racemic mixtures, single enantiomers, diastereomeric compounds and single diastereomers.
  • the asymmetric center that can exist depends on the nature of the various substituents on the molecule. Each such asymmetric center will independently produce two optical isomers, and all possible optical isomers and diastereomeric mixtures and pure or partially pure compounds are included within the scope of the present invention.
  • the invention includes all isomeric forms of the compounds.
  • the compound represented by the general formula (A) of the present invention can be prepared by the following method, but the conditions of the method, such as reactants, solvents, acids and bases, the amount of the compound used, the reaction temperature, and the time required for the reaction are not limited to the following explanation of.
  • the compound of the present invention can also optionally be conveniently prepared by combining various synthetic methods described in the present specification or known in the art, and such combination can be easily performed by those skilled in the art to which the present invention belongs.
  • the compound represented by the general formula (A) of the present invention can be synthesized by the following method:
  • active substance of the invention or “active compound of the invention” refers to a compound of the invention, its optical isomers, cis-trans isomers, or agrochemically acceptable salts, which have significantly increased insecticidal activity , And an expanded insecticidal spectrum.
  • pesticologically acceptable salt means that the anion of the salt is known and acceptable when forming a pharmaceutically acceptable salt of a pesticide.
  • the salt is preferably water-soluble.
  • Suitable acid addition salts formed from compounds of formula (A) include salts formed from inorganic acids, such as hydrochloride, phosphate, sulfate, nitrate; and salts including organic acids, such as acetate, Benzoate.
  • the active substance of the present invention can be used to control and eliminate a wide range of agricultural and forestry plant pests, stored cereal pests, public health pests, pests endangering animal health, and the like.
  • insecticide is a collective term for a substance having an action to control all the pests mentioned above.
  • pests include, but are not limited to: Coleoptera insects: Sitophilus zeamais, Tribolium castaneum, Henosepilachna vigintioctomaculata, Henosepilachna sparsa, fine-breasted hoe Insects (Agriotes fuscicollis), red-footed green beetle (Anomala cupripes), four-striped beetle (Popillia quadriguttata), potato leaf beetle (Monolepta hieroglyphica), monochamus (Monochamus alternatus), rice root elephant (Echinocnemus squameme) Basiprionota bisignata, Anoplophora chinensis, Apripera germari, Scolytus schevy, or Agriotes fuscicollis.
  • Coleoptera insects Sitophilus zeamais, Tribolium castaneum, Henosepilachna vigintio
  • Lepidoptera insects Lymantria dispar, Malacosoma neustria testacea, Diaphania perspectalis, Clania variegata, Cnidocampa flaguescens, Dendrolimus punctatus), archaea moth (Orgyia gonostigma), poplar wing moth (Paranthrene tabaniformis), Spodoptera litura, Chilo suppressalis, corn borer (Ostrinia nunubilalis), Ephestia baccautella, Cotton roll moth (Adoxophyes ororana), chestnut small roll moth (laspyresia splendana), small ground tiger (Agrotis fucosa), great wax owl (Galleria mellonella), vegetable moth (Plutella xylostella), orange moth (Phyllocnistis citcitrella), or oriental Mythimna separata.
  • Homoptera insects Nephotettix cincticeps, Nilaparvata lugens, Pseudococcus comstocki, Unaspis yanonensis, Myzus persicae, Aphis gossydii ), Radish aphids (Lipaphis erysimi pseudobrassicae), Stephanitis nashi, or whitefly (Bemisia tabaci).
  • Orthoptera insects Blattella germanica, Periplaneta americana, Gryllotalpa africana, or Locus migratoria.
  • Isoptera insects Solenopsis invicta, or Coptotermes formosanus. Diptera insects: Musca domestica, Aedes aegypti, Delia platura, Culex sp., Or Anopheles sinensis.
  • the compounds involved in the present invention are particularly effective against agricultural and forestry pests such as aphids, leafhoppers, planthoppers, thrips, and whiteflies, as well as hygienic pest mosquito larvae.
  • the active substance of the present invention can be prepared into a pesticide composition by a conventional method.
  • These active compounds can be formulated into conventional formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules; aerosols, natural and synthetic materials impregnated with active substances, in polymer Microcapsules, seed coatings, and preparations for use with combustion devices, such as smoke cartridges, cans, and trays, as well as ULV Cold Mist and Hot Mist ( Warm).
  • compositions can be produced by known methods, for example, by mixing an active compound with an extender, which is a liquid or liquefied gas or solid diluent or carrier, and optionally a surfactant such as an emulsifier and / or Dispersant and / or foam former.
  • an extender which is a liquid or liquefied gas or solid diluent or carrier
  • a surfactant such as an emulsifier and / or Dispersant and / or foam former.
  • organic solvents can also be used as auxiliaries.
  • liquid solvents as diluents or carriers, such as: aromatic hydrocarbons, such as xylene, toluene or alkyl naphthalene; chlorinated aromatic or chlorinated aliphatic hydrocarbons, such as chlorobenzene, vinyl chloride or Dichloromethane; aliphatic hydrocarbons, such as cyclohexane or paraffin, such as mineral oil fractions; alcohols, such as ethanol or ethylene glycol, and their ethers and lipids; ketones, such as acetone, methyl ethyl ketone, methyl isobutyl Ketones or cyclohexanone; or polar solvents that are not commonly used, such as dimethylformamide and dimethylsulfoxide, and water.
  • Liquefied gas diluent or carrier refers to a liquid that will become a gas at normal temperature and pressure, such as aerosol propellants, such as halogenated hydrocarbons, butane, propane,
  • the solid support can be ground minerals such as kaolin, clay, talc, quartz, activated clay, montmorillonite, or diatomaceous earth, and ground synthetic minerals such as highly dispersed silicic acid, alumina, and silicates. .
  • the solid carriers for granules are crushed and graded natural spar, such as calcite, marble, pumice, sepiolite, and dolomite, as well as granules made from inorganic and organic meals, and organic materials such as sawdust, coconut shell, Corn on the cob and tobacco stems.
  • Non-ionic and anionic emulsifying columns can be used as emulsifiers and / or foam formers.
  • polyoxyethylene-fatty acid esters polyoxyethylene-fatty alcohol ethers, such as alkylaryl polyethylene glycol ethers, alkyl sulfonates, alkyl sulfates, aryl sulfonates and white Protein hydrolysate.
  • Dispersants include, for example, lignin sulfite waste liquor and methyl cellulose.
  • Binders such as carboxymethyl cellulose and natural and synthetic polymers in the form of powders, granules or emulsions can be used in the formulations, such as gum arabic, polyvinyl alcohol and polyvinyl acetate.
  • Colorants such as inorganic dyes, such as iron oxide, diamond oxide, and Prussian blue; organic dyes, such as organic dyes, such as chloro dyes or metal titanium cyanine dyes; and trace nutritional agents, such as iron, manganese, boron, copper , Cobalt, aluminum and zinc salts, etc.
  • active compounds of the present invention may be present in a commercial formulation or in a dosage form prepared from these formulations in a mixture with other active compounds including, but not limited to, pesticides, bait, fungicides, Acaricides, thread killers, fungicides, growth control agents, etc.
  • Insecticides include, for example, phosphates, carbamates, pyrethroids, chlorinated hydrocarbons, benzoylureas, wormworm toxins, and substances produced by microorganisms such as avermectin.
  • the active compounds of the present invention can also be formulated as a mixture with a synergist in their commercial formulations to be used in dosage forms prepared from these formulations.
  • a synergist is a compound that enhances the action of an active compound. Since the active compound itself is active, it is not necessary to add a synergist.
  • formulations usually contain the active compound of the invention in an amount of 0.001-99.99% by weight, preferably 0.01-99.9% by weight, and more preferably 0.05-90% by weight of the insecticide composition.
  • concentration of the active compound in a dosage form prepared from a commercial preparation can be varied within a wide range.
  • concentration of the active compound in the dosage form used may be from 0.0000001 to 100% (g / v), preferably between 0.0001 and 1%.
  • a class of photochromic diarylethylene compounds containing GABA receptor inhibitor units provided by the present invention has obvious photochromism, good thermal stability, and good fatigue resistance.
  • the ring product has high insecticidal activity and can be used as an insecticide to control agricultural pests. At the same time, it provides a new method for the study of GABA receptors.
  • reaction solution was naturally warmed to room temperature, and the reaction was quenched with 2M hydrochloric acid (15 mL). The layers were separated. The aqueous layer was extracted three times with anhydrous ether and combined. There are several layers, and then washed three times with water. The organic layer is dried over anhydrous sodium sulfate, filtered, and the solvent is removed under reduced pressure to obtain 2.0 g of an oily liquid. This crude product is directly put into the next step of deprotection reaction without further separation.
  • reaction mixture was then extracted with ether (30 mL ⁇ 2), and the combined organic phases were washed with 30 mL of saturated sodium bicarbonate, dried over anhydrous sodium sulfate, filtered, and the solvent was removed under reduced pressure to give 0.35 g of a pale yellow solid with a yield of 92%. Since the product was very unstable in air, it was immediately put into the next reaction without purification.
  • the organic phase is separated and the aqueous layer is separated.
  • Extract with anhydrous ether 50mL ⁇ 2), combine the organic phases, adjust to neutrality with saturated sodium bicarbonate solution, then wash with water, wash with saturated sodium chloride solution, dry over anhydrous magnesium sulfate overnight, and remove a large amount of solvent by rotary evaporation.
  • the obtained viscous black crude product was passed through a silica gel column (7: 3, v / v) with petroleum ether and ethyl acetate, and the solvent was evaporated to obtain 16 g of a pale yellow solid powder with a yield of 59%.
  • reaction mixture was then extracted with diethyl ether (30 mL x 2), and the combined organic phases were washed with 30 mL of saturated sodium bicarbonate, dried over anhydrous sodium sulfate, filtered, and the solvent was removed under reduced pressure to give a brown solid. Since the product was very unstable in air, it was immediately put into the next reaction without purification.
  • the synthesis method is the same as that of compound 2, step 2.6, except that the fipronil is replaced by N-methyl fipronil.
  • the synthetic method is the same as that of compound 1, step 1.7; the difference is that fipronil is replaced by N-methyl fipronil.
  • the synthesis method is the same as that of compound 1, step 1.7; the difference is that fipronil is replaced with N-butyl fipronil.
  • the synthesis method is the same as that of compound 1, step 1.7. Under nitrogen and 50 ° C oil bath conditions, a 50 mL round bottom flask was charged with N-methyl fipronil (0.202 g, 0.45 mmol) and N-butyl fipronil (0.221). g, 0.45 mmol) and cesium carbonate (0.949 g, 2.17 mmol), dissolved by adding 30 mL of dimethylformamide, and stirred at 50 ° C for half an hour under constant temperature stirring. Then slowly add 1,2-bis (2-methyl-5-chloromethyl-3-thienyl) octafluorocyclopentene dissolved in 5 mL of dimethylformamide, and continue the reaction at constant temperature for 4 h.
  • the synthetic method is the same as that of compound 6; the difference is that N-butyl fipronil is replaced with fipronil.
  • Aphids are commonly known as greasy or honey bugs, belonging to the homoptera order, and are a common crop pest. Aphids are mainly distributed in temperate and subtropical regions of the northern hemisphere, and they are rarely distributed in tropical regions. Aphids are pests of stinging mouthparts, often clustering in leaves, tender stems, flower buds, and top buds, etc., sucking juice, causing the leaves to shrink, curl, and deform, causing severe withering or even death of the entire plant. Honeydew secreted by aphids can also cause coal pollution, virus disease and attract ants. Aphids have strong reproduction and adaptability, and various control methods are difficult to achieve a curative effect. For the control of aphids, it is important to control them to prevent aphids from occurring in large numbers. Bean aphid (Aphis craccivora) was used as a test object, and the test was performed by dipping method.
  • the starved bean aphids were shaken around the bean seedlings, and the aphids were allowed to climb the seedlings in the sun, and punctured the needles (which took about 2 to 3 hours), and finally each bean seedling was crawled with about 20 to 30 aphids.
  • the compound solution with the required concentration was prepared and divided into two groups. The first group was not irradiated with ultraviolet light (unlighted group), and the second group was irradiated with 310nm ultraviolet light for a certain period of time (lighted group, placed in dark conditions).
  • the content of DMSO in the solution does not exceed 5%, and the solution contains a small amount of the surfactant Tritraton (2 to 3 drops of Tritraton in 500ml of water).
  • Aedes albopictus is commonly known as black mosquito, flower mosquito, spotted mosquito, flower foot mosquito, fierce and aggressive, also known as "Asian tiger mosquito", belonging to the family Aceridae, medium size Black mosquitoes with markings formed by white scales.
  • Aedes albopictus originated from Southeast Asia and is a common mosquito species in Southeast Asia and China.
  • Aedes albopictus larvae (pupa) invertebrates, insects, larvae of Diptera. It is hatched from eggs laid by female mosquitoes in fresh water. Its body is slender, its chest is wider than its head and abdomen, and its body flexes and stretches when swimming.
  • the water environment is quiet and shady, and it is not easy to be disturbed. ⁇
  • the body is slender and dark brown, swimming vertically in the water, feeding on bacteria and unicellular algae in the water, and breathing air.
  • Larvae mainly accumulate water in bamboo tubes, tree holes, stone caves, waste tires, and tanks, earthenware bowls, and pickle tanks near the human house. They are also found in the leaf axils of plants such as pineapples. The tadpoles develop into tadpoles after 4 molts.
  • the tadpoles can still move in the early stage, but they are basically immobile when they emerge, and then become mosquitoes.
  • Aedes albopictus is both a highly aggressive mosquito and an important viral vector. It can transmit many pathogens, including dengue, Ross River virus, and West Nile virus.
  • Comprehensive mosquito control methods include environmental control, biological control, chemical control, regulatory control and genetic control.
  • the chemical control is through the injection of the breeding ground, which has a good effect on the direct spraying of Aedes albopictus adult mosquitoes, but it has caused considerable pollution to the environment while investing a large amount of human, material and financial resources, and the application of chemical drugs It also makes mosquitoes resistant. Therefore, research on high-efficiency, low-toxic insecticides to kill mosquito larvae can effectively control the increase in the number of mosquitoes and inhibit the spread of human diseases.
  • Operation process Select a few 4th instar Aedes albopictus larvae with the same size. Dilute the test compound with DMSO (the content of DMSO in the solution does not exceed 5%), dilute it with dechlorinated water, and accurately prepare 800, 400, 200, 100, 50, 25, 12.5, 6.25, 3.13, 1.57ppm solutions. Two sets of experiments were set up, the first group was not irradiated with ultraviolet light (unlighted group), and the second group was irradiated with 310nm ultraviolet light for a certain time (lighted group, placed in dark conditions). Then take 2 mL of the compound of each concentration and add it to a 4 mL centrifuge tube, and then transfer 30 maggots into the corresponding centrifuge tube.
  • Photochromism refers to compound A, which can undergo a specific chemical reaction after being irradiated with light of a specific wavelength, thereby producing product B, and can be restored to the original under the action of light of another wavelength of light or heat. State of the phenomenon.
  • Diarylvinyl compounds are also a class of organic photochromic compounds based on pericyclic reactions.
  • the parent structure of these compounds is a 6 ⁇ electron-conjugated hexatriene.
  • molecules in antiparallel state undergo an intramolecular cyclotron ring-closing reaction to form a conjugated closed-loop molecule and appear colored.
  • the closed-loop molecules return to the original state.
  • the closed-loop state of such compounds can show all colors from yellow to green.
  • the acetonitrile solution of ring-opening compound 1 was irradiated with ultraviolet light at 310 nm.
  • the ring-opening compound 1 slowly formed ring-closed compound 1.
  • a broad absorption peak appeared at 520 nm in the visible light region.
  • the intensity of the absorption peak increases.
  • compound 1 reached the equilibrium state of open-loop and closed-loop ( Figure 1). It can be observed that the color of the solution quickly changed from colorless to red, which indicates that compound 1 had closed-loop light under the action of ultraviolet light. Discoloration reaction.
  • the ring-closed compound 1 was irradiated with blue light at 493 nm, and the solution color was observed to change from red to colorless, indicating that the ring-closed compound 1 had a photochromic reaction of ring-opening under visible light.
  • Example 3 shows that the insecticidal effect of the ring-closure compound is better.
  • Fatigue resistance is an evaluation index based on the number of cycles between coloration and decolorization of a compound undergoing photochromism. Photochromic reactions are always accompanied by changes in chemical bonds. In this process, the occurrence of side reactions is inevitable. This will undoubtedly lead to partial degradation of the compound and reduce the fatigue resistance of the compound. Apart from the environmental factors, the fatigue resistance of diarylethylene compounds is also affected by the differences in their molecular structure. In terms of molecular structure, the type of substituents on aryl groups will greatly affect its fatigue resistance, and asymmetric structures can also improve the fatigue resistance of compounds.
  • dibenzothiophene perfluorocyclopent-based compound has high general fatigue endurance, number of cycles in the air can be up to 104 or more.
  • the acetonitrile solution of Compound 1 When the acetonitrile solution of Compound 1 was irradiated with ultraviolet light and visible light alternately, it exhibited good photochromic properties. When irradiated with 310 nm ultraviolet light, the acetonitrile solution of Compound 1 changed from colorless to red, and a new characteristic absorption peak appeared near 550 nm, which indicates that it forms a closed-loop compound. When the light is larger than 493nm, the red color of the solution disappears, and the ring-opened compound undergoes a ring-opening reaction to become a ring-opened compound.
  • the following components were prepared in proportion: 25% (weight percent, the same below) of any one of compounds 1-7; 5% polyoxyethylene sorbitol hexaoleate; 70% higher aliphatic hydrocarbon oil.
  • the components are ground together in a sand mill until the solid particles fall below about 5 microns.
  • the obtained viscous suspension can be used directly, but it can also be used after emulsified in water.
  • the following components were prepared in proportion: 25% of any one of compounds 1-7; 3% hydrated attapulgit; 10% calcium lignosulfonate; 0.5% sodium dihydrogen phosphate; and 61.5% water.
  • the components are ground together in a ball mill until the solid particles fall below about 10 microns. This aqueous suspension can be used directly.
  • Edible bait can be dispersed to places where sanitary pests infect, such as domestic or industrial places, such as kitchens, hospitals or shops or outdoor areas, to control the pests by oral ingestion.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Disclosed are a diarylethene compound and a preparation and use thereof, wherein the structural formula of same is as shown in formula (A). Such compounds are a class of good photochromic compounds, and will perform a photoisomerization reaction under irradiation by light of a specific wavelength to generate a ring-closing compound; and the compounds and their ring-closing derivatives after photoisomerization have a high activity against agroforestry pest aphids, and larvae of Aedes albopictus, Nematocera, Culicidae, etc., and the activity of the ring-closing compound after illumination is higher than that of the ring-opening compound before illumination.

Description

二芳基乙烯类化合物及其制备和用途Diaryl vinyl compounds and preparation and use thereof 技术领域Technical field
本发明属于农药和医药领域。具体地,本发明涉及一种光致变色二芳基乙烯类化合物、及其制备方法和应用。The invention belongs to the fields of pesticides and medicine. Specifically, the present invention relates to a photochromic diaryl vinyl compound, and a preparation method and application thereof.
技术背景technical background
1952年,Hirshberg首次定义了光致变色。光致异构化合物也可称为光致变色化合物或者光控开关,该类化合物一般存在两种异构体,它们在吸收光谱、空间几何结构和偶极矩等方面表现着不同的物理化学性质。在不同波长的光照射下,化合物可以在两种异构体之间相互转换且这种转换是可逆的;它们具有不同的吸收光谱,可以产生可逆的颜色变化。迄今为止,人们已对光致异构材料已经有了很多的研究,该类化合物已经在光信息存储、液晶材料、分子开关以及生物等方面有了广泛的应用。由于光致异构化合物具有优异的光物理化学性能,很多新型的光致异构化合物也在不断开发。In 1952, Hirshberg first defined photochromism. Photoisomers can also be called photochromic compounds or light-controlled switches. There are two types of isomers in these compounds. They show different physical and chemical properties in terms of absorption spectrum, spatial geometry, and dipole moment. . Under different wavelengths of light, compounds can convert between two isomers and this conversion is reversible; they have different absorption spectra and can produce reversible color changes. So far, there have been many studies on photo-isomer materials, and these compounds have been widely used in optical information storage, liquid crystal materials, molecular switches, and biology. Due to the excellent photophysical and chemical properties of photoisomers, many new photoisomers are also being developed.
在光致异构类有机化合物中,二芳基乙烯扮演了非常重要的角色。杂环取代的二芳基乙烯类化合物具有一个共扼六电子的己三烯母体结构,它的光致变色基于分子内的环合反应(周环反应)。在紫外光激发下,化合物顺旋闭环生成成色体,成色体在可见光照射下又能发生相反的变化,发生了热不可逆光致变色反应,,化合物普遍表现出来良好的热稳定性和耐疲劳性从而受到了人们的极大关注。该结构作为光致变色发生的核心单元而大受关注,通过其结构优化获得新的功能型化合物成为热点,所以近来该结构的合成与修饰也屡屡创新,备受瞩目。In photoisomers, diarylethylene plays a very important role. Heterocyclic substituted diarylethylene compounds have a hexatriene parent structure that conjugates six electrons, and its photochromism is based on an intramolecular cyclization reaction (pericyclic reaction). Under the excitation of ultraviolet light, the compound spins in a closed loop to form a chromophore. The chromophore can undergo opposite changes under visible light irradiation, and a thermal irreversible photochromic reaction occurs. The compound generally exhibits good thermal stability and fatigue resistance. It has received great attention from people. This structure has attracted much attention as the core unit of photochromic generation. It has become a hotspot to obtain new functional compounds through the optimization of its structure, so the synthesis and modification of this structure have also been repeatedly innovated and attracted much attention recently.
基于二芳基乙烯特殊的光致异构性质,人们开发出多种光致变色功能材料并将其广泛应用于超高密度光信息存储、分子开关、分子逻辑门、分子导线、光电材料、多光子器件、表面/纳米器件、液晶材料、化学传感、生物成像、自组装、聚集诱导发光、光控生物体系等诸多领域。其中,二芳基乙烯类化合物因其出色的热稳定性、优良的耐疲劳性、快的响应速率、高的转化率和量子产率以及出色的固相反应活性而成为理想的光致变色材料之一。Based on the special photoisomerization properties of diarylethylene, people have developed a variety of photochromic functional materials and widely used them in ultra-high density optical information storage, molecular switches, molecular logic gates, molecular wires, optoelectronic materials, and more Photonic devices, surface / nano devices, liquid crystal materials, chemical sensing, biological imaging, self-assembly, aggregation-induced luminescence, light-controlled biological systems, and many other fields. Among them, diarylvinyl compounds are ideal photochromic materials due to their excellent thermal stability, excellent fatigue resistance, fast response rate, high conversion and quantum yield, and excellent solid-phase reactivity. one.
大部分二芳基乙烯类化合物可通过光致异构化作用改变其分子两端首尾距离,从而引起目标生物分子功能性改变,如果在开环或关环状态下,能使目标生物分子完全成非活性或活性状态,二芳基乙烯光开关可能将是最有效的。在平稳的黑暗环境中,二芳基乙烯化合物以更稳定的开环构型存在。用紫外光照射可转化为大量的关环结构,而在加热或蓝光照射下关环又可转变为开环结构。二芳基依稀类的化合物已应用于光控耦合的光异构化反应,包括体外的多肽、蛋白质和核酸以及体内的离子通道和受体。Most diarylvinyl compounds can change the end-to-end distance of the two ends of the molecule through photoisomerization, thereby causing the functional changes of the target biomolecules. If the target biomolecules are opened or closed, the target biomolecules can be completely Inactive or active states, diarylethylene optical switches will probably be the most effective. In a stable dark environment, diarylethylene compounds exist in a more stable ring-opening configuration. Irradiation with ultraviolet light can transform into a large number of closed-loop structures, and closed-loop structures can be transformed into open-loop structures under heat or blue light. Diaryl dilute compounds have been used in light-controlled coupling isomerization reactions, including peptides, proteins, and nucleic acids in vitro and ion channels and receptors in vivo.
γ-氨基丁酸(GABA)受体广泛存在于脊椎动物和昆虫中枢神经系统中,可由神经递质γ-氨基丁酸以及一些外源性的药物进行调控。人类的许多精神疾病如癫痫、精 神分裂症、失眠、酒精中毒、帕金森综合症等都与GABA受体有关。γ-aminobutyric acid (GABA) receptors are widely present in the central nervous system of vertebrates and insects, and can be regulated by the neurotransmitter γ-aminobutyric acid and some exogenous drugs. Many human mental illnesses such as epilepsy, schizophrenia, insomnia, alcoholism, and Parkinson's syndrome are all related to GABA receptors.
为了提高作用于GABA受体的配体的选择性以及活性的精确的控制,近年来,研究者们将光致异构结构引入GABA受体配体中,设计了光致异构GABA受体配体,实现了从时间和空间上对受体的精准调控。In order to improve the selectivity of ligands acting on GABA receptors and the precise control of their activities, in recent years, researchers have introduced photoisomerized structures into GABA receptor ligands and designed photoisomerized GABA receptor ligands. Body, to achieve precise regulation of receptors in time and space.
本领域技术人员致力于研发一种光致变色明显、热稳定性好、抗疲劳性好且杀虫活性高的光致异构GABA受体配体。Those skilled in the art are devoted to the research and development of a photoisomeric GABA receptor ligand with obvious photochromism, good thermal stability, good fatigue resistance, and high insecticidal activity.
发明内容Summary of the invention
本发明的目的之一在于提供一类可作为GABA受体配体的光致异构化合物及其制备方法。One of the objectives of the present invention is to provide a class of photoisomer compounds that can be used as GABA receptor ligands and a method for preparing the same.
本发明的另一目的在于提供上述化合物在防治害虫等方面的应用。Another object of the present invention is to provide applications of the above compounds in controlling pests and the like.
本发明第一方面提供了具有式(A)所示结构的化合物、或所述化合物的光学异构体、顺反异构体或其盐:A first aspect of the present invention provides a compound having a structure represented by formula (A), or an optical isomer, cis-trans isomer of the compound, or a salt thereof:
Figure PCTCN2019093093-appb-000001
Figure PCTCN2019093093-appb-000001
式(A)中:In formula (A):
R 1,R 2各自独立地为H、取代或未取代的C 1-6烷基、烯丙基、苄基、取代或未取代的C 1-4烷氧基-C 1-6烷基、取代或未取代的C 1-6烷基-羰基、取代或未取代的C 1-4烷氧基-羰基或苯氧羰基;或者R 1和R 2共同构成-CH 2-CH 2-或-CH 2-CH 2-CH 2-; R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
各个R 3分别独立地为氢、取代或未取代的C 1-4烷基、卤原子、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟、C 1-4烷基、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环;或R 4、R 5、R 8和R 9中的一种和R 6或R 7的结合构成取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
各个R 10分别独立地为C 1-4烷基或C 1-4烷氧基; Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy;
Z选自S、O或NH;Z is selected from S, O or NH;
其中,上述的取代是指氢原子被选自下组的基团所取代:卤原子、C 1-6烷基或卤代C 1-6烷基、C 1-6烷氧基或卤代C 1-6烷氧基、C 2-6烯基、C 2-6炔基、卤代的C 2-6烯基、卤代的C 2-6炔基、C 1-4烷氧基-C 1-6烷基、C 1-6烷氧基-羰基、C 2-6炔基-羰基、C 2-6烯基-羰基。 Wherein, the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group. 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkenyl, halogenated C 2-6 alkynyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-carbonyl, C 2-6 alkynyl-carbonyl, C 2-6 alkenyl-carbonyl.
在一个优选例中,R 1,R 2各自独立地为氢或C 1-4烷基。 In a preferred embodiment, R 1 and R 2 are each independently hydrogen or C 1-4 alkyl.
在一个优选例中,R 1,R 2各自独立地为氢、甲基、乙基、正丙基、异丙基、正丁 基、异丁基或叔丁基。 In a preferred embodiment, R 1 and R 2 are each independently hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or tert-butyl.
在一个优选例中,各个R 3分别独立地为氢、C 1-3烷基或卤原子。 In a preferred example, each R 3 is independently a hydrogen, a C 1-3 alkyl group or a halogen atom.
在一个优选例中,各个R 3分别独立地为氢。 In a preferred example, each R 3 is independently hydrogen.
在一个优选例中,R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟或C 1-4烷基; In a preferred example, R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine or C 1-4 alkyl;
在一个优选例中,R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢或氟。 In a preferred example, R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen or fluorine.
在一个优选例中,各个R 10分别独立地为C 1-2烷基或C 1-2烷氧基。 In a preferred embodiment, each R 10 is independently a C 1-2 alkyl group or a C 1-2 alkoxy group.
在一个优选例中,各个R 10分别独立地为甲基。 In a preferred example, each R 10 is independently a methyl group.
在一个优选例中,Z为S。In a preferred example, Z is S.
本发明第二方面提供了具有式(B)所示结构的化合物、或所述化合物的光学异构体、顺反异构体或其盐:A second aspect of the present invention provides a compound having a structure represented by formula (B), or an optical isomer, cis-trans isomer of the compound, or a salt thereof:
Figure PCTCN2019093093-appb-000002
Figure PCTCN2019093093-appb-000002
式(B)中:In formula (B):
R 1,R 2各自独立地为H、取代或未取代的C 1-6烷基、烯丙基、苄基、取代或未取代的C 1-4烷氧基-C 1-6烷基、取代或未取代的C 1-6烷基-羰基、取代或未取代的C 1-4烷氧基-羰基或苯氧羰基;或者R 1和R 2共同构成-CH 2-CH 2-或-CH 2-CH 2-CH 2-; R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
各个R 3分别独立地为氢、取代或未取代的C 1-4烷基、卤原子、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟、C 1-4烷基、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环;或R 4、R 5、R 8和R 9中的一种和R 6或R 7的结合构成取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
各个R 10分别独立地为C 1-4烷基或C 1-4烷氧基; Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy;
Z选自S、O或NH;Z is selected from S, O or NH;
其中,上述的取代是指氢原子被选自下组的基团所取代:卤原子、C 1-6烷基或卤代C 1-6烷基、C 1-6烷氧基或卤代C 1-6烷氧基、C 2-6烯基、C 2-6炔基、卤代的C 2-6烯基、卤代的C 2-6炔基、C 1-4烷氧基-C 1-6烷基、C 1-6烷氧基-羰基、C 2-6炔基-羰基、C 2-6烯基-羰基。 Wherein, the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group. 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkenyl, halogenated C 2-6 alkynyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-carbonyl, C 2-6 alkynyl-carbonyl, C 2-6 alkenyl-carbonyl.
本发明第三方面提供了一种杀虫剂组合物,其包含0.001-99.99重量%的成分(a)和成分(b);其中,A third aspect of the present invention provides a pesticide composition comprising 0.001-99.99% by weight of the component (a) and the component (b); wherein,
成分(a)为第一方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;和/或第二方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;Component (a) is a compound according to the first aspect, or an optical isomer, a cis-trans isomer, or a salt thereof; and / or a compound according to the second aspect, or an optical isomer of the compound Structure, cis-trans isomer or salt thereof;
成分(b)为农药学上可接受的载体和/或赋形剂。Ingredient (b) is a pesticidely acceptable carrier and / or excipient.
在一个优选例中,成分(a)占所述杀虫剂组合物的0.01-99.9重量%,优选0.05-90 重量%。In a preferred example, the component (a) accounts for 0.01-99.9% by weight, and preferably 0.05-90% by weight of the pesticide composition.
在一个优选例中,所述杀虫剂组合物用于杀灭或预防选自如下的害虫:鞘翅目、鳞翅目、半翅目、直翅目、等翅目、或双翅目昆虫。In a preferred example, the insecticide composition is used to kill or prevent a pest selected from the group consisting of Coleoptera, Lepidoptera, Hemiptera, Orthoptera, Isoptera, or Diptera insects.
在另一优选例中,所述害虫优选等翅目或鳞翅目昆虫。In another preferred example, the pest is preferably an Isoptera or Lepidoptera insect.
在一个优选例中,所述害虫具有刺吸式或锉吸式口器。In a preferred example, the pest has a mouth suction or file suction mouthpiece.
在另一优选例中,所述害虫为蚜虫、孑孓、飞虱、粉虱、叶蝉、蓟马、棉铃虫、菜青虫、小菜蛾、斜纹夜蛾、粘虫。In another preferred example, the pests are aphids, maggots, planthoppers, whitefly, leafhoppers, thrips, cotton bollworm, cabbage worm, diamondback moth, Spodoptera litura, and armyworm.
在另一优选例中,所述杀虫剂还包含其它活性物质,所述其它活性物质选自:杀虫剂、饵剂、杀菌剂、杀螨剂、杀线虫剂、杀真菌剂或生长控制剂,以及将该杀虫剂组合物应用于危害动物健康的害虫中。In another preferred example, the insecticide further comprises other active substances selected from the group consisting of: insecticides, baits, fungicides, acaricides, nematicides, fungicides, or growth control Agents, and application of the pesticide composition to pests that endanger animal health.
本发明第四方面提供了一种杀虫和/或防虫方法,所述方法包括将如下一种或多种施加于遭受或可能遭受虫害的植物体、其周围的土壤或环境中:A fourth aspect of the present invention provides an insecticidal and / or pest control method, which comprises applying one or more of the following to a plant body that has suffered or is likely to suffer from pests, the surrounding soil, or the environment:
第一方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;The compound of the first aspect, or an optical isomer, cis-trans isomer of the compound, or a salt thereof;
第二方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;The compound of the second aspect, or an optical isomer, cis-trans isomer of the compound, or a salt thereof;
第三方面所述的杀虫剂组合物;The insecticide composition according to the third aspect;
并任选地用波长为310-380nm的光照射该植物体、其周围的土壤或环境。The plant body, the surrounding soil, or the environment is optionally illuminated with light having a wavelength of 310-380 nm.
本发明第五方面提供了第一方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;第二方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;或第三方面所述的杀虫剂组合物,在制备杀虫剂组合物中的用途。A fifth aspect of the present invention provides the compound according to the first aspect, or the optical isomer, cis-trans isomer, or a salt thereof; the compound according to the second aspect, or the optical isomerization of the compound Or a cis-trans isomer or a salt thereof; or the use of the insecticide composition according to the third aspect in the preparation of an insecticide composition.
本发明第六方面提供了第一方面的化合物、或所述化合物的光学异构体、顺反异构体或其盐的用途,所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐在310-380nm波长的光照射后生成第二方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;A sixth aspect of the present invention provides the compound of the first aspect, or the use of an optical isomer, cis-trans isomer, or a salt of the compound, the compound, or the optical isomer, cis, The trans isomer or a salt thereof generates a compound according to the second aspect, or an optical isomer, a cis-trans isomer, or a salt thereof, after irradiation with light having a wavelength of 310-380 nm;
Figure PCTCN2019093093-appb-000003
Figure PCTCN2019093093-appb-000003
各式中:Of the various types:
R 1,R 2各自独立地为H、取代或未取代的C 1-6烷基、烯丙基、苄基、取代或未取代的C 1-4烷氧基-C 1-6烷基、取代或未取代的C 1-6烷基-羰基、取代或未取代的C 1-4烷氧基-羰基或苯氧羰基;或者R 1和R 2共同构成-CH 2-CH 2-或-CH 2-CH 2-CH 2-; R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
各个R 3分别独立地为氢、取代或未取代的C 1-4烷基、卤原子、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟、C 1-4烷基、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环;或R 4、R 5、R 8和R 9中的一种和R 6或R 7的结 合构成取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
各个R 10分别独立地为C 1-4烷基或C 1-4烷氧基; Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy;
Z选自S、O或NH;Z is selected from S, O or NH;
其中,上述的取代是指氢原子被选自下组的基团所取代:卤原子、C 1-6烷基或卤代C 1-6烷基、C 1-6烷氧基或卤代C 1-6烷氧基、C 2-6烯基、C 2-6炔基、卤代的C 2-6烯基、卤代的C 2-6炔基、C 1-4烷氧基-C 1-6烷基、C 1-6烷氧基-羰基、C 2-6炔基-羰基、C 2-6烯基-羰基。 Wherein, the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group. 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkenyl, halogenated C 2-6 alkynyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-carbonyl, C 2-6 alkynyl-carbonyl, C 2-6 alkenyl-carbonyl.
本发明第七方面提供了第二方面所述的化合物,或所述化合物的光学异构体、顺反异构体或其盐的用途,所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐在大于493nm(优选为493-760nm)波长的光照下生成第一方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;A seventh aspect of the present invention provides the compound described in the second aspect, or the use of an optical isomer, cis-trans isomer, or a salt of the compound, the compound, or the optical isomer of the compound 1. The cis-trans isomer or salt thereof generates a compound described in the first aspect, or an optical isomer, cis-trans isomer or salt thereof, under light having a wavelength of more than 493 nm (preferably 493-760 nm). ;
Figure PCTCN2019093093-appb-000004
Figure PCTCN2019093093-appb-000004
各式中:Of the various types:
R 1,R 2各自独立地为H、取代或未取代的C 1-6烷基、烯丙基、苄基、取代或未取代的C 1-4烷氧基-C 1-6烷基、取代或未取代的C 1-6烷基-羰基、取代或未取代的C 1-4烷氧基-羰基或苯氧羰基;或者R 1和R 2共同构成-CH 2-CH 2-或-CH 2-CH 2-CH 2-; R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
各个R 3分别独立地为氢、取代或未取代的C 1-4烷基、卤原子、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟、C 1-4烷基、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环;或R 4、R 5、R 8和R 9中的一种和R 6或R 7的结合构成取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
各个R 10分别独立地为C 1-4烷基或C 1-4烷氧基; Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy;
Z选自S、O或NH;Z is selected from S, O or NH;
其中,上述的取代是指氢原子被选自下组的基团所取代:卤原子、C 1-6烷基或卤代C 1-6烷基、C 1-6烷氧基或卤代C 1-6烷氧基、C 2-6烯基、C 2-6炔基、卤代的C 2-6烯基、卤代的C 2-6炔基、C 1-4烷氧基-C 1-6烷基、C 1-6烷氧基-羰基、C 2-6炔基-羰基、C 2-6烯基-羰基。 Wherein, the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group. 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkenyl, halogenated C 2-6 alkynyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-carbonyl, C 2-6 alkynyl-carbonyl, C 2-6 alkenyl-carbonyl.
本发明第八方面提供了第一方面所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐的制备方法,An eighth aspect of the present invention provides a method for preparing a compound according to the first aspect, or an optical isomer, a cis-trans isomer, or a salt thereof,
(a)当R1与R2相同时,所述方法包括步骤:在惰性溶剂中,将式(1g)化合物与式01或01’化合物反应,从而得到式(A)化合物;(a) When R1 is the same as R2, the method includes the step of: reacting a compound of formula (1g) with a compound of formula 01 or 01 'in an inert solvent to obtain a compound of formula (A);
Figure PCTCN2019093093-appb-000005
Figure PCTCN2019093093-appb-000005
上述各式中,各个基团的定义同前且R1与R2相同;In the above formulas, the definition of each group is the same as above and R1 and R2 are the same;
or
(b)当R1与R2不相同时,所述方法包括步骤:在惰性溶剂中,将式(1g)化合物与式01化合物反应,从而得到式(1h)化合物;和在惰性溶剂中,将式(1h)化合物与式01’化合物反应,从而得到式(A)化合物;(b) when R1 and R2 are different, the method includes the steps of: reacting a compound of formula (1g) with a compound of formula 01 in an inert solvent to obtain a compound of formula (1h); and in an inert solvent, (1h) reacting a compound with a compound of formula 01 'to obtain a compound of formula (A);
Figure PCTCN2019093093-appb-000006
Figure PCTCN2019093093-appb-000006
上述各式中,各个基团的定义同前且R1与R2不相同;In the above formulas, the definition of each group is the same as above and R1 and R2 are different;
or
(c)当R1与R2不相同时,所述方法包括步骤:在惰性溶剂中,将式(1g)化合物与式01化合物和式01’化合物反应,从而得到式(A)化合物;(c) When R1 and R2 are different, the method includes the step of: reacting a compound of formula (1g) with a compound of formula 01 and a compound of formula 01 'in an inert solvent to obtain a compound of formula (A);
Figure PCTCN2019093093-appb-000007
Figure PCTCN2019093093-appb-000007
上述各式中,各个基团的定义同前且R1与R2不相同。In the above formulae, the definition of each group is the same as above and R1 and R2 are different.
在另一优选例中,所述式(1g)化合物的制备方法包括步骤:In another preferred example, the method for preparing the compound of formula (1g) includes steps:
(1)在惰性溶剂中,将式(1a)化合物与溴进行亲核反应,得到式(1b)化合物;(1) nucleophilic reaction of a compound of formula (1a) with bromine in an inert solvent to obtain a compound of formula (1b);
(2)在惰性溶剂中,将式(1b)化合物与乙二醇进行保护反应,得到式(1c)化合物;(2) protecting the compound of formula (1b) with ethylene glycol in an inert solvent to obtain a compound of formula (1c);
(3)在惰性溶剂中,将式(1c)化合物经正丁基锂拔溴后再与
Figure PCTCN2019093093-appb-000008
反应,得式(1d)化合物;
(3) In an inert solvent, extract the compound of formula (1c) with
Figure PCTCN2019093093-appb-000008
Reaction to obtain a compound of formula (1d);
(4)在惰性溶剂中,将式(1d)化合物进行脱保护反应,得到式(1e)化合物;(4) deprotecting the compound of formula (1d) in an inert solvent to obtain a compound of formula (1e);
(5)在惰性溶剂中,将式(1e)化合物进行还原反应,得到式(1f)化合物;(5) reducing the compound of formula (1e) in an inert solvent to obtain a compound of formula (1f);
(6)在惰性溶剂中,将式(1f)化合物进行氯化反应,得到式(1g)化合物:(6) The compound of formula (1f) is subjected to a chlorination reaction in an inert solvent to obtain a compound of formula (1g):
Figure PCTCN2019093093-appb-000009
Figure PCTCN2019093093-appb-000009
上述各式中,各个基团的定义同前。In the above formulas, the definitions of the respective groups are the same as above.
在另一优选例中,所述式(1g)化合物的制备方法包括步骤:In another preferred example, the method for preparing the compound of formula (1g) includes steps:
(1)在惰性溶剂中,将式(2a)化合物与
Figure PCTCN2019093093-appb-000010
进行傅克酰化反应,得到式(2b)化合物:
(1) In an inert solvent, combine the compound of formula (2a) with
Figure PCTCN2019093093-appb-000010
A Fuke acylation reaction is performed to obtain a compound of formula (2b):
(2)在惰性溶剂中,将式(2b)化合物进行关环反应,得到式(2c)化合物:(2) The compound of formula (2b) is subjected to a ring-closure reaction in an inert solvent to obtain a compound of formula (2c):
(3)在惰性溶剂中,将式(2c)化合物经正丁基锂拔氯再与二甲基甲酰胺反应,得式(1e)化合物:(3) The compound of the formula (2c) is extracted with n-butyllithium and then reacted with dimethylformamide in an inert solvent to obtain a compound of the formula (1e):
(4)在惰性溶剂中,将式(1e)化合物进行还原反应,得到式(1f)化合物:(4) The compound of formula (1e) is subjected to a reduction reaction in an inert solvent to obtain a compound of formula (1f):
(5)在惰性溶剂中,将式(1f)化合物进行氯化反应,得到式(1g)化合物:(5) The compound of formula (1f) is subjected to a chlorination reaction in an inert solvent to obtain a compound of formula (1g):
Figure PCTCN2019093093-appb-000011
Figure PCTCN2019093093-appb-000011
上述各式中,各个基团的定义同前。In the above formulas, the definitions of the respective groups are the same as above.
应理解,在本发明范围内中,本发明的上述各技术特征和在下文(如实施例)中具体描述的各技术特征之间都可以互相组合,从而构成新的或优选的技术方案。限于篇幅,在此不再一一累述。It should be understood that, within the scope of the present invention, the above technical features of the present invention and the technical features specifically described in the following (such as the embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, I will not repeat them here.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为发明的化合物1在乙腈溶液中紫外光照射前后的吸收光谱图。FIG. 1 is an absorption spectrum chart of the compound 1 of the invention before and after irradiation with ultraviolet light in an acetonitrile solution.
图2显示了发明的化合物1在特定波长处的抗疲劳性。Figure 2 shows the fatigue resistance of Compound 1 of the invention at specific wavelengths.
具体实施方式detailed description
本发明人通过长期而深入的研究,发现将二芳基乙烯片段引入已经商品化的氟虫腈,合成了一类含GABA受体抑制剂单元的光致变色二芳基乙烯类化合物,该化合物光照关环产物杀虫活性高。在此基础上,发明人完成了本发明。Through long-term and in-depth research, the inventors discovered that a diarylethylene fragment was introduced into a commercial fipronil to synthesize a class of photochromic diarylethylene compounds containing a GABA receptor inhibitor unit. The compound Light-enclosed products have high insecticidal activity. On this basis, the inventors have completed the present invention.
基团定义Group definition
如本文所用,术语“C 1-4烷基”指具有1-4个碳原子的直链或支链烷基,例如甲基、乙基、丙基、异丙基、丁基、异丁基、仲丁基、叔丁基、或类似基团。 As used herein, the term "C 1-4 alkyl" refers to a straight or branched chain alkyl group having 1-4 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl , Sec-butyl, tert-butyl, or similar groups.
术语“C 1-4烷氧基”指具有1-4个碳原子的直链或支链烷氧基,例如甲氧基、乙氧基、丙氧基、异丙氧基、丁氧基、异丁氧基、仲丁氧基、叔丁氧基、或类似基团。 The term "C 1-4 alkoxy" refers to a straight or branched chain alkoxy group having 1-4 carbon atoms, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, Isobutoxy, sec-butoxy, t-butoxy, or similar groups.
如本文所用,术语“C 2-6烯基”指具有2-6个碳原子的直链或支链烯基,例如乙烯基、丙烯基、异丙烯基、丁烯基、异丁烯基、仲丁烯基、或类似基团。 As used herein, the term "C 2-6 alkenyl" refers to a straight or branched chain alkenyl group having 2 to 6 carbon atoms, such as vinyl, propenyl, isopropenyl, butenyl, isobutenyl, sec-butyl Alkenyl, or similar.
如本文所用,术语“C 2-6炔基”指具有2-6个碳原子的直链或支链炔基,例如乙炔基、丙炔基、异丙炔基、丁炔基、异丁炔基、仲丁炔基、或类似基团。 As used herein, the term "C 2-6 alkynyl" refers to a straight or branched chain alkynyl group having 2 to 6 carbon atoms, such as ethynyl, propynyl, isopropynyl, butynyl, isobutynyl Group, sec-butynyl, or similar group.
术语“卤原子”指氟、氯、溴、或碘。术语“卤代的”指被相同或不同的一个或多个上述卤原子取代的基团,例如三氟甲基、五氟乙基、或类似基团。The term "halogen atom" refers to fluorine, chlorine, bromine, or iodine. The term "halo" refers to a group substituted with one or more of the above-mentioned halogen atoms, such as trifluoromethyl, pentafluoroethyl, or similar groups.
术语“杂环”指形成所述杂环骨架的原子中至少一个原子不是碳,为氮、氧或硫。通常,杂环包含不超过4个氮、不超过2个氧和/或不超过2个硫。除非另外指明,杂环可以是饱和的、部分不饱和的或完全不饱和的环。例如吡啶基、噻唑基、三唑基、嘧啶基、二氢呋喃基、四氢呋喃基、噁唑基、哌啶基、哌嗪基、吡咯基、吗啉基、吲哚基等。The term "heterocyclic" means that at least one of the atoms forming the heterocyclic skeleton is not carbon and is nitrogen, oxygen or sulfur. Generally, heterocycles contain no more than 4 nitrogens, no more than 2 oxygens, and / or no more than 2 sulfurs. Unless otherwise specified, heterocycles can be saturated, partially unsaturated, or fully unsaturated rings. For example, pyridyl, thiazolyl, triazolyl, pyrimidinyl, dihydrofuryl, tetrahydrofuryl, oxazolyl, piperidinyl, piperazinyl, pyrrolyl, morpholinyl, indolyl, and the like.
术语“5~6元杂环”是指具有5-6个环原子的饱和的、部分不饱和的或完全不饱和的杂环,例如吡啶基、噻唑基、三唑基、嘧啶基、二氢呋喃基、四氢呋喃基、噁唑基、哌啶基、哌嗪基、吡咯基、吗啉基等。The term "5- to 6-membered heterocyclic ring" refers to a saturated, partially unsaturated or fully unsaturated heterocyclic ring having 5-6 ring atoms, such as pyridyl, thiazolyl, triazolyl, pyrimidinyl, dihydro Furyl, tetrahydrofuryl, oxazolyl, piperidinyl, piperazinyl, pyrrolyl, morpholinyl, and the like.
术语“5~6元芳杂环基”是指具有5-6个环原子的完全不饱和的杂环,例如吡啶基、噻唑基、嘧啶基或噁唑基等。The term "5- to 6-membered aromatic heterocyclic group" refers to a completely unsaturated heterocyclic ring having 5 to 6 ring atoms, such as pyridyl, thiazolyl, pyrimidinyl, or oxazolyl, and the like.
术语“6~10元芳环基”指具有6-10个碳原子的芳基,例如苯基、萘基等。The term "6- to 10-membered aromatic ring group" refers to an aryl group having 6 to 10 carbon atoms, such as phenyl, naphthyl, and the like.
术语“光致变色”是指一个化合物(A),在收到一定波长的光照射时,可进行特定的化学反应或物理效应,获得产物(B),由于结构的改变导致其(可见部分的)吸收光谱发生明显的变化。而在另一波长的光照射或热的作用下,产物(B)又能恢复到原来的形式。The term "photochromic" refers to a compound (A), which can undergo a specific chemical reaction or physical effect when receiving a certain wavelength of light, to obtain the product (B), which is caused by the structural change (the visible part of the A significant change in the absorption spectrum occurred. Under the action of light of another wavelength or heat, the product (B) can return to its original form.
术语“关环产物”是指二芳基乙烯类化合物经特定波长紫外光照射后,发生分子内周环反应关环后得到的化合物。The term "ring-closing product" refers to a compound obtained after a diarylethene compound is irradiated with ultraviolet light of a specific wavelength, and a ring closure reaction occurs in the molecule.
术语“抗疲劳性”是指基于化合物经历光致变色的呈色和消色之间循环次数的评价指标。The term "fatigue resistance" refers to an evaluation index based on the number of cycles between the coloration and decolorization of a compound undergoing photochromism.
术语“惰性溶剂”指的是不与原料发生反应的各种溶剂,包括各种直链、支链或环状的醇,醚或酮,卤代烷,1,4-二氧六环,乙腈,四氢呋喃,N,N-二甲基甲酰胺(DMF),二甲基亚砜(DMSO)等。The term "inert solvent" refers to a variety of solvents that do not react with the starting materials, including various linear, branched or cyclic alcohols, ethers or ketones, haloalkanes, 1,4-dioxane, acetonitrile, tetrahydrofuran , N, N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), etc.
本文所用的“组合物”指任何混合物。可以是溶液、混合液、液体、粉末、油膏、水性的、非水性的或他们的任何组合。As used herein, "composition" refers to any mixture. It can be a solution, a mixture, a liquid, a powder, an ointment, an aqueous, a non-aqueous, or any combination thereof.
这里使用的任何保护性基团,氨基酸和其他化合物的缩写,与他们通用的、公认的缩写或IUPAC-IUB委员会颁布的生化命名一致,除非特别说明。The abbreviations of any protective groups, amino acids, and other compounds used herein are consistent with their common and recognized abbreviations or biochemical nomenclature issued by the IUPAC-IUB Committee, unless specifically stated otherwise.
本发明的化合物可以含有一个或多个不对称中心,并因此以消旋体、外消旋混合物、单一对映体、非对映异构体化合物和单一非对映体的形式出现。可以存在的不对 称中心,取决于分子上各种取代基的性质。每个这种不对称中心将独立地产生两个旋光异构体,并且所有可能的旋光异构体和非对映体混合物和纯或部分纯的化合物包括在本发明的范围之内。本发明包括化合物的所有异构形式。The compounds of the invention may contain one or more asymmetric centers and therefore appear as racemates, racemic mixtures, single enantiomers, diastereomeric compounds and single diastereomers. The asymmetric center that can exist depends on the nature of the various substituents on the molecule. Each such asymmetric center will independently produce two optical isomers, and all possible optical isomers and diastereomeric mixtures and pure or partially pure compounds are included within the scope of the present invention. The invention includes all isomeric forms of the compounds.
本发明化合物的制备方法Preparation method of the compound of the present invention
本发明通式(A)所示化合物可通过如下的方法制得,然而该方法的条件,例如反应物、溶剂、酸碱、所用化合物的量、反应温度、反应所需时间等并不限于下面的解释。本发明化合物还可以任选地通过将在本说明书中描述的或本领域已知的各种合成方法组合起来而方便的制得,这样的组合可由本发明所属领域的技术人员容易地进行。The compound represented by the general formula (A) of the present invention can be prepared by the following method, but the conditions of the method, such as reactants, solvents, acids and bases, the amount of the compound used, the reaction temperature, and the time required for the reaction are not limited to the following explanation of. The compound of the present invention can also optionally be conveniently prepared by combining various synthetic methods described in the present specification or known in the art, and such combination can be easily performed by those skilled in the art to which the present invention belongs.
本发明通式(A)所示化合物可通过如下的方法合成:The compound represented by the general formula (A) of the present invention can be synthesized by the following method:
(A)当R1与R2相同时,所述方法包括步骤:(A) When R1 is the same as R2, the method includes steps:
(1)在惰性溶剂中,将式(1a)化合物与溴进行亲核反应,得到式(1b)化合物;(1) nucleophilic reaction of a compound of formula (1a) with bromine in an inert solvent to obtain a compound of formula (1b);
(2)在惰性溶剂中,将式(1b)化合物与乙二醇进行保护反应,得到式(1c)化合物;(2) protecting the compound of formula (1b) with ethylene glycol in an inert solvent to obtain a compound of formula (1c);
(3)在惰性溶剂中,将式(1c)化合物经正丁基锂拔溴后再与
Figure PCTCN2019093093-appb-000012
反应,得式(1d)化合物;
(3) In an inert solvent, extract the compound of formula (1c) with
Figure PCTCN2019093093-appb-000012
Reaction to obtain a compound of formula (1d);
(4)在惰性溶剂中,将式(1d)化合物进行脱保护反应,得到式(1e)化合物;(4) deprotecting the compound of formula (1d) in an inert solvent to obtain a compound of formula (1e);
(5)在惰性溶剂中,将式(1e)化合物进行还原反应,得到式(1f)化合物;(5) reducing the compound of formula (1e) in an inert solvent to obtain a compound of formula (1f);
(6)在惰性溶剂中,将式(1f)化合物进行氯化反应,得到式(1g)化合物:(6) The compound of formula (1f) is subjected to a chlorination reaction in an inert solvent to obtain a compound of formula (1g):
(7)在惰性溶剂中,将式(1g)化合物与式01或01’化合物反应,从而得到式(A)化合物;(7) reacting a compound of formula (1g) with a compound of formula 01 or 01 'in an inert solvent to obtain a compound of formula (A);
Figure PCTCN2019093093-appb-000013
Figure PCTCN2019093093-appb-000013
上述各式中,各个基团的定义同前且R1与R2相同;In the above formulas, the definition of each group is the same as above and R1 and R2 are the same;
或(B)当R1与R2相同时,所述方法包括步骤:Or (B) when R1 and R2 are the same, the method includes the steps:
(1)在惰性溶剂中,将式(2a)化合物与
Figure PCTCN2019093093-appb-000014
进行傅克酰化反应,得到式(2b)化合物:
(1) In an inert solvent, combine the compound of formula (2a) with
Figure PCTCN2019093093-appb-000014
A Fuke acylation reaction is performed to obtain a compound of formula (2b):
(2)在惰性溶剂中,将式(2b)化合物进行关环反应,得到式(2c)化合物:(2) The compound of formula (2b) is subjected to a ring-closure reaction in an inert solvent to obtain a compound of formula (2c):
(3)在惰性溶剂中,将式(2c)化合物经正丁基锂拔氯再与二甲基甲酰胺反应,得式(1e)化合物:(3) The compound of formula (2c) is extracted with n-butyllithium in chlorine and reacted with dimethylformamide in an inert solvent to obtain a compound of formula (1e):
(4)在惰性溶剂中,将式(1e)化合物进行还原反应,得到式(1f)化合物:(4) The compound of formula (1e) is subjected to a reduction reaction in an inert solvent to obtain a compound of formula (1f):
(5)在惰性溶剂中,将式(1f)化合物进行氯化反应,得到式(1g)化合物:(5) The compound of formula (1f) is subjected to a chlorination reaction in an inert solvent to obtain a compound of formula (1g):
(6)在惰性溶剂中,将式(1g)化合物与式01或01’化合物反应,从而得到式(A)化合物;(6) reacting a compound of formula (1g) with a compound of formula 01 or 01 'in an inert solvent to obtain a compound of formula (A);
Figure PCTCN2019093093-appb-000015
Figure PCTCN2019093093-appb-000015
上述各式中,各个基团的定义同前且R1与R2相同;In the above formulas, the definition of each group is the same as above and R1 and R2 are the same;
或(C)当R1与R2不相同时,所述方法包括步骤:Or (C) when R1 and R2 are different, the method includes the steps:
(1)在惰性溶剂中,将式(1a)化合物与溴进行亲核反应,得到式(1b)化合物;(1) nucleophilic reaction of a compound of formula (1a) with bromine in an inert solvent to obtain a compound of formula (1b);
(2)在惰性溶剂中,将式(1b)化合物与乙二醇进行保护反应,得到式(1c)化合物;(2) protecting the compound of formula (1b) with ethylene glycol in an inert solvent to obtain a compound of formula (1c);
(3)在惰性溶剂中,将式(1c)化合物经正丁基锂拔溴后再与
Figure PCTCN2019093093-appb-000016
反应,得式(1d)化合物;
(3) In an inert solvent, extract the compound of formula (1c) with
Figure PCTCN2019093093-appb-000016
Reaction to obtain a compound of formula (1d);
(4)在惰性溶剂中,将式(1d)化合物进行脱保护反应,得到式(1e)化合物;(4) deprotecting the compound of formula (1d) in an inert solvent to obtain a compound of formula (1e);
(5)在惰性溶剂中,将式(1e)化合物进行还原反应,得到式(1f)化合物;(5) reducing the compound of formula (1e) in an inert solvent to obtain a compound of formula (1f);
(6)在惰性溶剂中,将式(1f)化合物进行氯化反应,得到式(1g)化合物:(6) The compound of formula (1f) is subjected to a chlorination reaction in an inert solvent to obtain a compound of formula (1g):
(7)在惰性溶剂中,将式(1g)化合物与式01化合物反应,从而得到式(1h)化合物;(7) reacting a compound of formula (1g) with a compound of formula 01 in an inert solvent to obtain a compound of formula (1h);
(8)在惰性溶剂中,将式(1h)化合物与式01’化合物反应,从而得到式(A)化合物;(8) reacting a compound of formula (1h) with a compound of formula 01 'in an inert solvent to obtain a compound of formula (A);
Figure PCTCN2019093093-appb-000017
Figure PCTCN2019093093-appb-000017
上述各式中,各个基团的定义同前且R1与R2不相同;In the above formulas, the definition of each group is the same as above and R1 and R2 are different;
或(C1)当R1与R2不相同时,所述方法包括步骤:Or (C1) When R1 and R2 are different, the method includes the steps:
方法(C)中的步骤(1)-(6);以及(7)在惰性溶剂中,将式(1g)化合物与式01化合物和式01’化合物反应,从而得到式(A)化合物;Steps (1)-(6) in method (C); and (7) reacting a compound of formula (1g) with a compound of formula 01 and a compound of formula 01 'in an inert solvent to obtain a compound of formula (A);
且上述各式中,各个基团的定义同前且R1与R2不相同。And in the above formulae, the definition of each group is the same as above and R1 and R2 are different.
或(D)当R1与R2不相同时,所述方法包括步骤:Or (D) when R1 and R2 are different, the method includes the steps:
(1)在惰性溶剂中,将式(2a)化合物与
Figure PCTCN2019093093-appb-000018
进行傅克酰化反应,得到式(2b)化合物:
(1) In an inert solvent, combine the compound of formula (2a) with
Figure PCTCN2019093093-appb-000018
A Fuke acylation reaction is performed to obtain a compound of formula (2b):
(2)在惰性溶剂中,将式(2b)化合物进行关环反应,得到式(2c)化合物:(2) The compound of formula (2b) is subjected to a ring-closure reaction in an inert solvent to obtain a compound of formula (2c):
(3)在惰性溶剂中,将式(2c)化合物经正丁基锂拔氯再与二甲基甲酰胺反应,得式(1e)化合物:(3) The compound of the formula (2c) is extracted with n-butyllithium and then reacted with dimethylformamide in an inert solvent to obtain a compound of the formula (1e):
(4)在惰性溶剂中,将式(1e)化合物进行还原反应,得到式(1f)化合物:(4) The compound of formula (1e) is subjected to a reduction reaction in an inert solvent to obtain a compound of formula (1f):
(5)在惰性溶剂中,将式(1f)化合物进行氯化反应,得到式(1g)化合物:(5) The compound of formula (1f) is subjected to a chlorination reaction in an inert solvent to obtain a compound of formula (1g):
(6)在惰性溶剂中,将式(1g)化合物与式01化合物反应,从而得到式(2g) 化合物;(6) reacting a compound of formula (1g) with a compound of formula 01 in an inert solvent to obtain a compound of formula (2g);
(7)在惰性溶剂中,将式(2g)化合物与式01’化合物反应,从而得到式(A)化合物;(7) reacting a compound of formula (2g) with a compound of formula 01 'in an inert solvent to obtain a compound of formula (A);
Figure PCTCN2019093093-appb-000019
Figure PCTCN2019093093-appb-000019
上述各式中,各个基团的定义同前且R1与R2不相同。In the above formulae, the definition of each group is the same as above and R1 and R2 are different.
或(D1)当R1与R2不相同时,所述方法包括步骤:Or (D1) When R1 and R2 are different, the method includes the steps:
方法(D)中的步骤(1)-(5);以及(6)在惰性溶剂中,将式(1g)化合物与式01化合物和式01’化合物反应,从而得到式(A)化合物;Steps (1)-(5) in method (D); and (6) reacting a compound of formula (1g) with a compound of formula 01 and a compound of formula 01 'in an inert solvent to obtain a compound of formula (A);
且上述各式中,各个基团的定义同前且R1与R2不相同。And in the above formulae, the definition of each group is the same as above and R1 and R2 are different.
本发明活性物质的杀虫活性Insecticidal activity of the active substance according to the invention
术语“本发明的活性物质”或“本发明的活性化合物”是指本发明化合物、其光学异构体、顺反异构体或农药学上可接受的盐,其具有显著提高的杀虫活性,以及扩大的杀虫谱。The term "active substance of the invention" or "active compound of the invention" refers to a compound of the invention, its optical isomers, cis-trans isomers, or agrochemically acceptable salts, which have significantly increased insecticidal activity , And an expanded insecticidal spectrum.
术语“农药学上可接受的盐”意指该盐的阴离子在形成杀虫剂药学上可接受的盐时为已了解的和可接受的。该盐较好的为水溶性的。合适的、由式(A)化合物形成的酸加成盐包括有无机酸形成的盐,例如盐酸盐、磷酸盐、硫酸盐、硝酸盐;及包括有机酸形成的盐,如醋酸盐,苯甲酸盐。The term "pesticologically acceptable salt" means that the anion of the salt is known and acceptable when forming a pharmaceutically acceptable salt of a pesticide. The salt is preferably water-soluble. Suitable acid addition salts formed from compounds of formula (A) include salts formed from inorganic acids, such as hydrochloride, phosphate, sulfate, nitrate; and salts including organic acids, such as acetate, Benzoate.
本发明的活性物质能用作控制和消灭广泛的农林植物害虫、贮藏谷类的害虫、公共卫生害虫以及危害动物健康的害虫等。在本说明书中,“杀虫剂”是具有防治上述提到的所有害虫的作用的物质的统称。害虫的例子包括但不限于:鞘翅目昆虫:玉米象(Sitophilus zeamais),赤拟谷盗(Tribolium castaneum),马铃薯瓢虫(Henosepilachna vigintioctomaculata),二十八星瓢虫(Henosepilachna sparsa),细胸叩头虫(Agriotes fuscicollis),红脚绿金龟(Anomala cupripes),四纹丽金龟(Popillia quadriguttata),马铃薯叶甲(Monolepta hieroglyphica),松天牛(Monochamus alternatus),稻根象(Echinocnemus squameus),泡桐叶甲(Basiprionota bisignata),星天牛(Anoplophora chinensis),桑天牛(Apripona germari),脐腹小蠹(Scolytus schevy),或细胸金针虫(Agriotes fuscicollis)。鳞翅目昆虫:舞毒娥(Lymantria dispar),天幕毛虫(Malacosoma neustria testacea),黄杨绢野螟(Diaphania perspectalis),大袋蛾(Clania variegata),黄刺蛾(Cnidocampa flauescens),马尾松毛虫(Dendrolimus punctatus),古毒蛾(Orgyia gonostigma),白杨透翅蛾(Paranthrene tabaniformis),斜纹夜蛾(Spodoptera litura),二化螟(Chilo suppressalis),玉米螟(Ostrinia nubilalis),粉斑螟(Ephestia cautella),棉卷蛾(Adoxophyes orana),栗子小卷蛾(laspyresia splendana),小地老虎(Agrotis fucosa),大蜡螟(Galleria mellonella),菜蛾(Plutella xylostella),桔潜蛾(Phyllocnistis citrella),或东方粘虫(Mythimna separata)。同翅目昆虫:黑尾叶蝉(Nephotettix cincticeps),稻褐飞虱(Nilaparvata lugens),康氏粉蚧(Pseudococcus comstocki),矢尖蚧(Unaspis yanonensis),桃蚜(Myzus persicae),棉蚜(Aphis gossydii),萝卜蚜(Lipaphis erysimi pseudobrassicae),梨班网蝽(Stephanitis nashi),或粉虱(Bemisia tabaci)。直翅目昆虫:德国小蠊(Blattella germanica),美国大蠊(Periplaneta american),非洲蝼蛄(Gryllotalpa africana),或亚洲飞蝗(Locus migratoria)。等翅目昆虫:入侵红火蚁(Solenopsis invicta),或家白蚁(Coptotermes formosanus)。双翅目昆虫:家蝇(Musca domestica),埃及伊蚊(Aedes aegypti),种蝇(Delia platura),库蚊(Culex sp.),或中华按蚊(Anopheles sinensis)。The active substance of the present invention can be used to control and eliminate a wide range of agricultural and forestry plant pests, stored cereal pests, public health pests, pests endangering animal health, and the like. In this specification, "insecticide" is a collective term for a substance having an action to control all the pests mentioned above. Examples of pests include, but are not limited to: Coleoptera insects: Sitophilus zeamais, Tribolium castaneum, Henosepilachna vigintioctomaculata, Henosepilachna sparsa, fine-breasted hoe Insects (Agriotes fuscicollis), red-footed green beetle (Anomala cupripes), four-striped beetle (Popillia quadriguttata), potato leaf beetle (Monolepta hieroglyphica), monochamus (Monochamus alternatus), rice root elephant (Echinocnemus squameme) Basiprionota bisignata, Anoplophora chinensis, Apripera germari, Scolytus schevy, or Agriotes fuscicollis. Lepidoptera insects: Lymantria dispar, Malacosoma neustria testacea, Diaphania perspectalis, Clania variegata, Cnidocampa flaguescens, Dendrolimus punctatus), archaea moth (Orgyia gonostigma), poplar wing moth (Paranthrene tabaniformis), Spodoptera litura, Chilo suppressalis, corn borer (Ostrinia nunubilalis), Ephestia baccautella, Cotton roll moth (Adoxophyes ororana), chestnut small roll moth (laspyresia splendana), small ground tiger (Agrotis fucosa), great wax owl (Galleria mellonella), vegetable moth (Plutella xylostella), orange moth (Phyllocnistis citcitrella), or oriental Mythimna separata. Homoptera insects: Nephotettix cincticeps, Nilaparvata lugens, Pseudococcus comstocki, Unaspis yanonensis, Myzus persicae, Aphis gossydii ), Radish aphids (Lipaphis erysimi pseudobrassicae), Stephanitis nashi, or whitefly (Bemisia tabaci). Orthoptera insects: Blattella germanica, Periplaneta americana, Gryllotalpa africana, or Locus migratoria. Isoptera insects: Solenopsis invicta, or Coptotermes formosanus. Diptera insects: Musca domestica, Aedes aegypti, Delia platura, Culex sp., Or Anopheles sinensis.
本发明涉及的化合物尤其对刺吸式、锉吸式口器害虫如:蚜虫、叶蝉、飞虱、蓟马、粉虱等农林害虫有特效以及对卫生害虫蚊子幼虫有特效。The compounds involved in the present invention are particularly effective against agricultural and forestry pests such as aphids, leafhoppers, planthoppers, thrips, and whiteflies, as well as hygienic pest mosquito larvae.
含本发明活性物质的杀虫剂组合物Insecticide composition containing active substance of the present invention
可将本发明的活性物质以常规的方法制备成杀虫剂组合物。这些活性化合物可做成常规的制剂,例如溶液剂,乳剂,混悬剂,粉剂,泡沫剂,糊剂,颗粒剂;气雾剂,用活性物质浸渍的天然的和合成的材料,在多聚物中的微胶囊,用于种子的包衣复方,和与燃烧装置—块使用的制剂,例如烟熏药筒,烟熏罐和烟熏盘,以及ULV冷雾(Cold  mist)和热雾(Warm mist)制剂。The active substance of the present invention can be prepared into a pesticide composition by a conventional method. These active compounds can be formulated into conventional formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules; aerosols, natural and synthetic materials impregnated with active substances, in polymer Microcapsules, seed coatings, and preparations for use with combustion devices, such as smoke cartridges, cans, and trays, as well as ULV Cold Mist and Hot Mist ( Warm).
这些制剂可用已知的方法生产,例如,将活性化合物与扩充剂混合,这些扩充剂就是液体的或液化气的或固体的稀释剂或载体,并可任意选用表面活性剂即乳化剂和/或分散剂和/或泡沫形成剂。例如在用水作扩充剂时,有机溶剂也可用作助剂。These preparations can be produced by known methods, for example, by mixing an active compound with an extender, which is a liquid or liquefied gas or solid diluent or carrier, and optionally a surfactant such as an emulsifier and / or Dispersant and / or foam former. For example, when using water as an extender, organic solvents can also be used as auxiliaries.
用液体溶剂作稀释剂或载体时基本上是合适的,如:芳香烃类,例如二甲苯,甲苯或烷基萘;氯化的芳香或氯化的脂肪烃类,例如氯苯,氯乙烯或二氯甲烷;脂肪烃类,例如环己烷或石蜡,例如矿物油馏分;醇类,例如乙醇或乙二醇以及它们的醚和脂类;酮类,例如丙酮,甲乙酮,甲基异丁基酮或环已酮;或不常用的极性溶剂,例如二甲基甲酰胺和二甲基亚砜,以及水。液化气的稀释剂或载体是指在常温常压下将成为气体的液体,例如气溶胶推进剂,如卤化的烃类以及丁烷,丙烷,氮气和二氧化碳。Basically suitable when using liquid solvents as diluents or carriers, such as: aromatic hydrocarbons, such as xylene, toluene or alkyl naphthalene; chlorinated aromatic or chlorinated aliphatic hydrocarbons, such as chlorobenzene, vinyl chloride or Dichloromethane; aliphatic hydrocarbons, such as cyclohexane or paraffin, such as mineral oil fractions; alcohols, such as ethanol or ethylene glycol, and their ethers and lipids; ketones, such as acetone, methyl ethyl ketone, methyl isobutyl Ketones or cyclohexanone; or polar solvents that are not commonly used, such as dimethylformamide and dimethylsulfoxide, and water. Liquefied gas diluent or carrier refers to a liquid that will become a gas at normal temperature and pressure, such as aerosol propellants, such as halogenated hydrocarbons, butane, propane, nitrogen and carbon dioxide.
固体载体可用地面天然的矿物质,例如高岭土,粘土,滑石,石英,活性白土,蒙脱土,或硅藻土,和地面合成的矿物质,例如高度分散的硅酸,氧化铝和硅酸盐。供颗粒用的固体载体是碾碎的和分级的天然告石,例如方解石,大理石,浮石,海泡石和白云石,以及无机和有机粗粉合成的颗粒,和有机材料例如锯木屑,椰子壳,玉米棒子和烟草梗的颗粒等。The solid support can be ground minerals such as kaolin, clay, talc, quartz, activated clay, montmorillonite, or diatomaceous earth, and ground synthetic minerals such as highly dispersed silicic acid, alumina, and silicates. . The solid carriers for granules are crushed and graded natural spar, such as calcite, marble, pumice, sepiolite, and dolomite, as well as granules made from inorganic and organic meals, and organic materials such as sawdust, coconut shell, Corn on the cob and tobacco stems.
非离子的和阴离子的乳化列可用作乳化剂和/或泡沫形成剂。例如聚氧乙烯-脂肪酸酯类,聚氧乙烯-脂肪醇醚类,例如烷芳基聚乙二醇醚类,烷基磺酸酯类,烷基硫酸酯类,芳基磺酸酯类以及白蛋白水解产物。分散剂包括,例如木质素亚硫酸盐废液和甲基纤维素。Non-ionic and anionic emulsifying columns can be used as emulsifiers and / or foam formers. For example polyoxyethylene-fatty acid esters, polyoxyethylene-fatty alcohol ethers, such as alkylaryl polyethylene glycol ethers, alkyl sulfonates, alkyl sulfates, aryl sulfonates and white Protein hydrolysate. Dispersants include, for example, lignin sulfite waste liquor and methyl cellulose.
在制剂中可以用粘合剂,例如羧甲基纤维素和以粉末,颗粒或乳液形式的天然和合成的多聚物,例如阿拉伯胶,聚乙烯基醇和聚乙烯醋酸酯。可以用着色剂例如无机染料,如氧化铁,氧化钻和普鲁士蓝;有机染料,如有机染料,如偶氯染料或金属钛菁染料;和用痕量营养剂,如铁,猛,硼,铜,钴,铝和锌的盐等。Binders such as carboxymethyl cellulose and natural and synthetic polymers in the form of powders, granules or emulsions can be used in the formulations, such as gum arabic, polyvinyl alcohol and polyvinyl acetate. Colorants such as inorganic dyes, such as iron oxide, diamond oxide, and Prussian blue; organic dyes, such as organic dyes, such as chloro dyes or metal titanium cyanine dyes; and trace nutritional agents, such as iron, manganese, boron, copper , Cobalt, aluminum and zinc salts, etc.
本发明的这些活性化合物可与其它活性化合物制成混合物存在于商品制剂中或从这些制剂制备的使用剂型中,所述其它的活性化合物包括但不限于:杀虫剂,合饵,杀菌剂,杀螨剂,杀线,杀真菌剂,生长控制剂等。杀虫剂包括,例如磷酸酯类,氨基甲酸酯类,除虫菊酯类,氯化烃类,苯甲酰脲类,沙蚕毒素类以及由微生物产生的物质,如阿维菌素。These active compounds of the present invention may be present in a commercial formulation or in a dosage form prepared from these formulations in a mixture with other active compounds including, but not limited to, pesticides, bait, fungicides, Acaricides, thread killers, fungicides, growth control agents, etc. Insecticides include, for example, phosphates, carbamates, pyrethroids, chlorinated hydrocarbons, benzoylureas, wormworm toxins, and substances produced by microorganisms such as avermectin.
此外,本发明的这些活性化合物也可与增效剂制成一种混合物存在于它们的商品制剂中成从这些制剂制备的使用剂型中。增效剂是提高活性化合物作用的化合物,由于活性化合物本身有活性,也可不必加增效剂。In addition, the active compounds of the present invention can also be formulated as a mixture with a synergist in their commercial formulations to be used in dosage forms prepared from these formulations. A synergist is a compound that enhances the action of an active compound. Since the active compound itself is active, it is not necessary to add a synergist.
这些制剂通常含有占所述杀虫剂组合物0.001-99.99重量%,优选0.01-99.9重量%,更优选0.05-90重量%的本发明的活性化合物。从商品制剂制成使用剂型中的活性化合物的浓度可在广阔的范围内变动。使用剂型中的活性化合物的浓度可从0.0000001-100%(g/v),最好在0.0001与1%之间。These formulations usually contain the active compound of the invention in an amount of 0.001-99.99% by weight, preferably 0.01-99.9% by weight, and more preferably 0.05-90% by weight of the insecticide composition. The concentration of the active compound in a dosage form prepared from a commercial preparation can be varied within a wide range. The concentration of the active compound in the dosage form used may be from 0.0000001 to 100% (g / v), preferably between 0.0001 and 1%.
基于光药理学(photopharmachology)基本原理,本发明提供的一类含GABA受体抑制剂单元的光致变色二芳基乙烯类化合物,光致变色明显,热稳定性好,抗疲劳性好,关环产物杀虫活性高,可用作杀虫剂,防治农业害虫,同时又为GABA受体的研究提供了一种新的方法。Based on the basic principles of photopharmachology, a class of photochromic diarylethylene compounds containing GABA receptor inhibitor units provided by the present invention has obvious photochromism, good thermal stability, and good fatigue resistance. The ring product has high insecticidal activity and can be used as an insecticide to control agricultural pests. At the same time, it provides a new method for the study of GABA receptors.
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件,或按照制造厂商所建议的条件。除非另外说明,否则百分比和份数按重量计算。其中,r.t.代表室温。The present invention will be further described below with reference to specific embodiments. It should be understood that these examples are only used to illustrate the present invention and not to limit the scope of the present invention. The experimental methods without specific conditions in the following examples are generally based on conventional conditions or conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are by weight. Among them, r.t. represents room temperature.
实施例1化合物1的合成Example 1 Synthesis of Compound 1
1.1制备4-溴-5-甲基-2-噻吩甲醛1.1 Preparation of 4-bromo-5-methyl-2-thienaldehyde
Figure PCTCN2019093093-appb-000020
Figure PCTCN2019093093-appb-000020
在100mL圆底烧瓶中加入5-甲基-2-噻吩甲醛(6.3g,50.0mmol)和50mL乙酸,然后用恒压滴液漏斗称取Br 2(8.78g,55.0mmol)溶于适量乙酸,室温下慢慢滴加溴的乙酸溶液,室温搅拌24h,TLC跟踪反应结束后,加入水停止反应。反应混合物用无水碳酸钠中和至中性。产物用乙醚萃取三次,有机相用无水硫酸钠干燥,过滤,减压除去溶剂得黑色液体,柱层析,用石油醚:乙酸乙酯=40:3(v:v)洗脱。蒸干溶剂得到白色固体3.1g,产率为30.1%。 1H NMR(400MHz,CDCl 3)δ9.78(s,1H),7.26(s,1H),2.49(s,3H). 13C NMR(101MHz,CDCl 3)δ181.60,145.84,140.12,138.73,111.24,15.93. In a 100 mL round-bottomed flask, add 5-methyl-2-thiophene formaldehyde (6.3 g, 50.0 mmol) and 50 mL of acetic acid, and then weigh Br 2 (8.78 g, 55.0 mmol) in a suitable amount of acetic acid using a constant pressure dropping funnel. Bromine acetic acid solution was slowly added dropwise at room temperature, and stirred at room temperature for 24 hours. After TLC followed the reaction, water was added to stop the reaction. The reaction mixture was neutralized to neutrality with anhydrous sodium carbonate. The product was extracted three times with ether, and the organic phase was dried over anhydrous sodium sulfate, filtered, and the solvent was removed under reduced pressure to obtain a black liquid. Column chromatography was eluted with petroleum ether: ethyl acetate = 40: 3 (v: v). The solvent was evaporated to dryness to obtain 3.1 g of a white solid with a yield of 30.1%. 1 H NMR (400MHz, CDCl 3 ) δ 9.78 (s, 1H), 7.26 (s, 1H), 2.49 (s, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 181.60, 145.84, 140.12, 138.73, 111.24 , 15.93.
1.2制备4-溴-5-甲基-2-(1,3-二氧戊环)噻吩1.2 Preparation of 4-bromo-5-methyl-2- (1,3-dioxolane) thiophene
Figure PCTCN2019093093-appb-000021
Figure PCTCN2019093093-appb-000021
在100mL圆底烧瓶中加入4-溴-5-甲基-2-噻吩甲醛(2.0g,9.75mmol)、乙二醇(Glycol)(1.23g,19.51mmol)和对甲苯磺酸(0.15g,97.53mmol),加入60mL苯(Benzene)溶解,装上分水器,搅拌回流(reflux)反应4h,TLC跟踪反应结束后,将反应液温度降至室温,用3.0mol/L的氢氧化钠溶液洗三次,再用水洗涤三次,有机相用无水硫酸钠干燥,过滤,减压除去溶剂得黄色液体,柱层析,用石油醚:乙酸乙酯=20:1(v:v)洗脱。蒸干溶剂得到白色油状物2.4g,产率为90.8%。 1H NMR(400MHz,CDCl 3)δ6.96(s,1H),6.00(s,1H),4.18-3.88(m,4H),2.38(s,3H). 13C NMR(101MHz,CDCl 3)δ138.70,135.35,128.79,108.45,99.69,65.19,14.86。 In a 100 mL round-bottomed flask, 4-bromo-5-methyl-2-thiophenealdehyde (2.0 g, 9.75 mmol), ethylene glycol (Glycol) (1.23 g, 19.51 mmol), and p-toluenesulfonic acid (0.15 g, 97.53mmol), add 60mL Benzene (Benzene) to dissolve, install a water separator, stir and reflux (reflux) for 4h, after TLC tracking the reaction is completed, reduce the temperature of the reaction solution to room temperature, use 3.0mol / L sodium hydroxide It was washed three times and then three times with water. The organic phase was dried over anhydrous sodium sulfate, filtered, and the solvent was removed under reduced pressure to obtain a yellow liquid. Column chromatography was eluted with petroleum ether: ethyl acetate = 20: 1 (v: v). The solvent was evaporated to obtain 2.4 g of a white oil with a yield of 90.8%. 1 H NMR (400MHz, CDCl 3 ) δ 6.96 (s, 1H), 6.00 (s, 1H), 4.18-3.88 (m, 4H), 2.38 (s, 3H). 13 C NMR (101MHz, CDCl 3 ) δ138.70, 135.35, 128.79, 108.45, 99.69, 65.19, 14.86.
1.3制备1,2-二[2-甲基-5-(1,3-二氧戊环)-3-噻吩基]八氟环戊烯1.3 Preparation of 1,2-bis [2-methyl-5- (1,3-dioxolane) -3-thienyl] octafluorocyclopentene
Figure PCTCN2019093093-appb-000022
Figure PCTCN2019093093-appb-000022
在氮气及-78℃条件下,在50mL低温反应瓶中加入4-溴-5-甲基-2-(1,3-二氧戊环)噻吩(2.4g,9.63mmol),加入30mL无水四氢呋喃,搅拌,慢慢用注射器加入2.5mol/L n-BuLi/正己烷(7.7mL,19.27mmol),继续低温搅拌反应40min,用预先冷却的注射器慢慢加入八氟环戊烯(1.23g,5.78mmol),继续低温搅拌反应2h,TLC跟踪反应结束后,将反应液自然升至室温,用浓度为2M的盐酸(15mL)淬灭反应,分液,水层用无水乙醚萃取三次,合并有几层,然后用水洗涤三次,有机层用无水硫酸钠干燥,过滤,减压除去溶剂得油状液体2.0g,此粗产物不需要进一步的分离,直接投入下一步脱保护反应。Under nitrogen and -78 ° C, add 4-bromo-5-methyl-2- (1,3-dioxolane) thiophene (2.4g, 9.63mmol) to a 50mL cryogenic reaction flask, and add 30mL of anhydrous Tetrahydrofuran, stir, slowly add 2.5mol / L n-BuLi / n-hexane (7.7mL, 19.27mmol) with a syringe, continue to stir the reaction at low temperature for 40min, and slowly add octafluorocyclopentene (1.23g, 5.78 mmol), continue to stir the reaction at low temperature for 2 h. After the completion of the TLC tracking reaction, the reaction solution was naturally warmed to room temperature, and the reaction was quenched with 2M hydrochloric acid (15 mL). The layers were separated. The aqueous layer was extracted three times with anhydrous ether and combined. There are several layers, and then washed three times with water. The organic layer is dried over anhydrous sodium sulfate, filtered, and the solvent is removed under reduced pressure to obtain 2.0 g of an oily liquid. This crude product is directly put into the next step of deprotection reaction without further separation.
1.4制备1,2-二(2-甲基-5-甲酰基-3-噻吩基)八氟环戊烯1.4 Preparation of 1,2-bis (2-methyl-5-formyl-3-thienyl) octafluorocyclopentene
Figure PCTCN2019093093-appb-000023
Figure PCTCN2019093093-appb-000023
在250mL圆底烧瓶中加入粗产物1,2-二[2-甲基-5-(1,3-二氧戊环)-3-噻吩基]八氟环戊烯(2.0g,3.90mmol)和对甲苯磺酸(0.4g,2.22mmol),加入混合溶剂水(30mL)和丙酮(acetone)(80mL)溶解,然后向混合物中加入2.0mL吡啶,搅拌回流反应24h。TLC跟踪反应结束后,将反应液温度降至室温,反应液分别饱和碳酸氢钠溶液和水洗涤,分液,水层用二氯甲烷萃取,合并有机相,用无水硫酸钠干燥,过滤,减压除去溶剂得黄色液体,柱层析,用石油醚:乙酸乙酯=1:5(v:v)洗脱。蒸干溶剂得到蓝色固体0.15g,产率为8.7%。 1H NMR(400MHz,CDCl 3)δ9.86(s,2H),7.74(s,2H),2.03(s,6H). 19F NMR(376MHz,CDCl 3)δ-110.30(t,J=5.1Hz,4F),-130.57--133.99(m,2F). In a 250 mL round bottom flask, add the crude product 1,2-di [2-methyl-5- (1,3-dioxolane) -3-thienyl] octafluorocyclopentene (2.0 g, 3.90 mmol) And p-toluenesulfonic acid (0.4g, 2.22mmol), mixed solvents of water (30mL) and acetone (80mL) were added to dissolve, then 2.0mL of pyridine was added to the mixture, and the reaction was stirred at reflux for 24h. After the TLC tracking reaction was completed, the temperature of the reaction solution was lowered to room temperature. The reaction solution was washed with saturated sodium bicarbonate solution and water, and the layers were separated. The aqueous layer was extracted with dichloromethane. The organic phases were combined, dried over anhydrous sodium sulfate, and filtered. The solvent was removed under reduced pressure to give a yellow liquid, which was subjected to column chromatography and eluted with petroleum ether: ethyl acetate = 1: 5 (v: v). The solvent was evaporated to give 0.15 g of a blue solid with a yield of 8.7%. 1 H NMR (400MHz, CDCl 3 ) δ9.86 (s, 2H), 7.74 (s, 2H), 2.03 (s, 6H). 19 F NMR (376MHz, CDCl 3 ) δ-110.30 (t, J = 5.1 Hz, 4F), -130.57--133.99 (m, 2F).
1.5制备1,2-二(2-甲基-5-羟甲基-3-噻吩基)八氟环戊烯1.5 Preparation of 1,2-bis (2-methyl-5-hydroxymethyl-3-thienyl) octafluorocyclopentene
Figure PCTCN2019093093-appb-000024
Figure PCTCN2019093093-appb-000024
在氮气及冰浴条件下,在50mL圆底烧瓶中加入1,2-二(2-甲基-5-甲酰基-3-噻吩基)八氟环戊烯(0.45g,1.06mmol),加入35mL甲醇溶解,然后分批加入硼氢化钠(0.16g,4.24mmol)。继续冰浴下搅拌反应1h,TLC跟踪反应结束后,加入适量的水淬灭反应,然后反应混合物用乙醚(30mL×2)萃取,合并有机相,有机相用饱和氯化钠溶液洗涤三次,无水硫酸钠干燥,过滤,减压除去溶剂得黄色固体,柱层析,用石油醚:乙酸乙酯=1:1(v:v)洗脱。蒸干溶剂得到白色固体0.45g,产率为99%。 1H  NMR(400MHz,CDCl 3)δ6.95(s,2H),4.76(s,4H),1.88(s,8H). 19F NMR(376MHz,CDCl 3)δ-110.10(t,J=10.9Hz,4F),-131.48--134.27(m,2F). Under nitrogen and ice bath conditions, add 1,2-bis (2-methyl-5-formyl-3-thienyl) octafluorocyclopentene (0.45 g, 1.06 mmol) to a 50 mL round bottom flask and add 35 mL of methanol was dissolved, and sodium borohydride (0.16 g, 4.24 mmol) was added in portions. The reaction was continued to be stirred in the ice bath for 1 h. After TLC followed the reaction, an appropriate amount of water was added to quench the reaction, and then the reaction mixture was extracted with ether (30 mL × 2). The organic phases were combined and the organic phase was washed three times with saturated sodium chloride solution. It was dried over sodium sulfate, filtered, and the solvent was removed under reduced pressure to obtain a yellow solid. Column chromatography was performed with petroleum ether: ethyl acetate = 1: 1 (v: v). The solvent was evaporated to dryness to obtain 0.45 g of a white solid with a yield of 99%. 1 H NMR (400MHz, CDCl 3 ) δ 6.95 (s, 2H), 4.76 (s, 4H), 1.88 (s, 8H). 19 F NMR (376MHz, CDCl 3 ) δ-110.10 (t, J = 10.9 Hz, 4F), -131.48--134.27 (m, 2F).
1.6制备1,2-二(2-甲基-5-氯甲基-3-噻吩基)八氟环戊烯1.6 Preparation of 1,2-bis (2-methyl-5-chloromethyl-3-thienyl) octafluorocyclopentene
Figure PCTCN2019093093-appb-000025
Figure PCTCN2019093093-appb-000025
在氮气及冰浴条件下,在100mL圆底烧瓶中加入1,2-二(2-甲基-5-羟甲基-3-噻吩基)八氟环戊烯(0.25g,0.58mmol)和无水吡啶(1.0mL),加入40mL无水四氢呋喃溶解,搅拌。将氯化亚砜(0.28g,2.33mmol)称在恒压滴液漏斗里,慢慢滴加到反应体系中,继续冰浴搅拌反应2h。TLC跟踪反应结束后,将反应液慢慢倒入40mL冰水混合物中,搅拌。然后反应混合物用乙醚(30mL×2)萃取,合并的有机相用30mL饱和碳酸氢钠洗涤,无水硫酸钠干燥,过滤,减压除去溶剂得淡黄色固体0.35g,产率为92%。由于产物在空气中非常不稳定,所以不进行纯化立即投入下一步反应中。Under nitrogen and ice bath conditions, in a 100 mL round-bottomed flask, add 1,2-bis (2-methyl-5-hydroxymethyl-3-thienyl) octafluorocyclopentene (0.25 g, 0.58 mmol) and Anhydrous pyridine (1.0 mL) was dissolved by adding 40 mL of anhydrous tetrahydrofuran and stirred. Thionyl chloride (0.28 g, 2.33 mmol) was weighed into a constant pressure dropping funnel, and slowly added dropwise to the reaction system, and the reaction was continued in an ice bath with stirring for 2 h. After the TLC tracking reaction was completed, the reaction solution was slowly poured into a 40 mL ice-water mixture and stirred. The reaction mixture was then extracted with ether (30 mL × 2), and the combined organic phases were washed with 30 mL of saturated sodium bicarbonate, dried over anhydrous sodium sulfate, filtered, and the solvent was removed under reduced pressure to give 0.35 g of a pale yellow solid with a yield of 92%. Since the product was very unstable in air, it was immediately put into the next reaction without purification.
1.7制备化合物11.7 Preparation of Compound 1
Figure PCTCN2019093093-appb-000026
Figure PCTCN2019093093-appb-000026
在氮气及50℃油浴条件下,在50mL圆底烧瓶中加入氟虫腈(0.421g,0.9mmol)和碳酸铯(0.949g,2.17mmol),加入30mL二甲基甲酰胺溶解,50℃恒温搅拌反应半个小时。然后慢慢加入用5mL二甲基甲酰胺溶解的1,2-二(2-甲基-5-氯甲基-3-噻吩基)八氟环戊烯,继续恒温反应4h。TLC跟踪反应结束后,过滤除去沉淀物,减压除去溶剂得棕红色固体,柱层析,用乙酸乙酯:石油醚=1:5(v:v)洗脱,蒸干溶剂得到白色固体0.35g,产率为28.3%。m.p.231.8-238.8℃. 1H NMR(400MHz,DMSO)δ8.40(s,2H),8.39-8.33(m,4H),7.04(d,J=5.2Hz,2H),4.71(dt,J=17.2,5.6Hz,2H),4.45(dd,J=17.6,6.4Hz,2H),1.80(d,J=4.4Hz,6H). 13C NMR(101MHz,DMSO)δ149.59,141.85,139.05,136.05,135.84,134.18,133.91,133.58,127.01,125.53,124.35,123.47,120.81,111.31,95.38,94.48,42.66,14.01. 19F NMR(376MHz,DMSO)δ-61.36--61.65(m),-73.32(t,J=8.3Hz),-108.91--109.89(m),-131.04--131.49(m).HRMS(ESI-TOF):m/z C 41H 18 35Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1286.8800,实测值:1286.8793;m/z C 41H 18 35Cl 3 37ClF 18N 8O 2S 4Na[M+Na] +计算值:1288.8770,实测值:1288.8760;m/z C 41H 18 35Cl 2 37Cl 2F 18N 8O 2S 4Na[M+Na] +计算值:1290.8741,实测值:1290.8707;m/z C 41H 18 35Cl 37Cl 3F 18N 8O 2S 4Na[M+Na] +计算值:1292.8711,实测值:1292.8723. Under nitrogen and 50 ° C oil bath conditions, put fipronil (0.421 g, 0.9 mmol) and cesium carbonate (0.949 g, 2.17 mmol) in a 50 mL round-bottomed flask, add 30 mL of dimethylformamide to dissolve, and keep the temperature at 50 ° C Stir the reaction for half an hour. Then slowly add 1,2-bis (2-methyl-5-chloromethyl-3-thienyl) octafluorocyclopentene dissolved in 5 mL of dimethylformamide, and continue the reaction at constant temperature for 4 h. After the completion of the TLC tracking reaction, the precipitate was removed by filtration, and the solvent was removed under reduced pressure to obtain a brown-red solid. Column chromatography was eluted with ethyl acetate: petroleum ether = 1: 5 (v: v). The solvent was evaporated to give a white solid 0.35. g, yield 28.3%. mp231.8-238.8 ℃. 1 H NMR (400 MHz, DMSO) δ 8.40 (s, 2H), 8.39-8.33 (m, 4H), 7.04 (d, J = 5.2 Hz, 2H), 4.71 (dt, J = 17.2, 5.6 Hz, 2H), 4.45 (dd, J = 17.6, 6.4 Hz, 2H), 1.80 (d, J = 4.4 Hz, 6H). 13 C NMR (101 MHz, DMSO) δ 149.59, 141.85, 139.05, 136.05 , 135.84,134.18,133.91,133.58,127.01,125.53,124.35,123.47,120.81,111.31,95.38,94.48,42.66,14.01. 19 F NMR (376MHz, DMSO) δ-61.36--61.65 (m),-73.32 ( t, J = 8.3Hz), -108.91--109.89 (m), -131.04--131.49 (m). HRMS (ESI-TOF): m / z C 41 H 18 35 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1286.8800, Measured value: 1286.8793; m / z C 41 H 18 35 Cl 3 37 ClF 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1288.8770, Measured Value: 1288.8760; m / z C 41 H 18 35 Cl 2 37 Cl 2 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated value: 1290.8741, Found: 1290.8707; m / z C 41 H 18 35 Cl 37 Cl 3 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1292.8711, Found: 1292.8723.
实施例2化合物2的合成Example 2 Synthesis of Compound 2
2.1制备1,5-二(5-氯-2-甲基噻吩-3-基)戊烷-1,5-二酮2.1 Preparation of 1,5-bis (5-chloro-2-methylthien-3-yl) pentane-1,5-dione
Figure PCTCN2019093093-appb-000027
Figure PCTCN2019093093-appb-000027
在50mL圆底烧瓶中依次加入无水三氯化铝(12.1g,90.49mmol)以及硝基甲烷150mL,冰浴条件下,先滴加戊二酰氯(6.37,37.71mmol)的硝基甲烷溶液,再滴加2-氯-5-甲基噻吩(10g,75.41mmol)的硝基甲烷溶液。加完后,继续反应0.5h,然后撤去冰浴,室温条件下继续搅拌反应6h,TLC跟踪反应结束后,小心慢慢加入60mL冰水混合物,继续搅拌5min,分液分出有机相,水层用无水乙醚(50mL×2)萃取,合并有机相,用饱和碳酸氢钠溶液调至中性,然后用水洗涤,饱和氯化钠溶液洗涤,无水硫酸镁干燥过夜,旋蒸除去大量溶剂,将得到的粘稠黑色粗产品用石油醚和乙酸乙醋过硅胶柱(7:3,v/v),蒸干溶剂得到16g淡黄色固体粉末,产率为59%。 1H NMR(400MHz,CDCl 3)δ7.19(s,2H),2.93-2.78(t,J=18Hz,4H),2.66(s,6H),2.06(m,2H). 13C NMR(101MHz,CDCl 3):δ194.7,147.6,134.7,126.7,125.2,40.4,18.1,16.0. In a 50 mL round-bottomed flask, anhydrous aluminum trichloride (12.1 g, 90.49 mmol) and 150 mL of nitromethane were sequentially added. Under an ice-bath condition, a solution of nitrosyl chloride (6.37, 37.71 mmol) was first added dropwise. A solution of 2-chloro-5-methylthiophene (10 g, 75.41 mmol) in nitromethane was added dropwise. After the addition is complete, continue the reaction for 0.5h, then remove the ice bath, and continue to stir the reaction for 6h at room temperature. After the TLC has followed the reaction, carefully add 60mL of ice-water mixture slowly and continue stirring for 5min. The organic phase is separated and the aqueous layer is separated. Extract with anhydrous ether (50mL × 2), combine the organic phases, adjust to neutrality with saturated sodium bicarbonate solution, then wash with water, wash with saturated sodium chloride solution, dry over anhydrous magnesium sulfate overnight, and remove a large amount of solvent by rotary evaporation. The obtained viscous black crude product was passed through a silica gel column (7: 3, v / v) with petroleum ether and ethyl acetate, and the solvent was evaporated to obtain 16 g of a pale yellow solid powder with a yield of 59%. 1 H NMR (400 MHz, CDCl 3 ) δ 7.19 (s, 2H), 2.93-2.78 (t, J = 18 Hz, 4H), 2.66 (s, 6H), 2.06 (m, 2H). 13 C NMR (101 MHz , CDCl 3 ): δ 194.7, 147.6, 134.7, 126.7, 125.2, 40.4, 18.1, 16.0.
2.2制备1,2-二(5-氯-2-甲基噻吩-3-基)环戊烯2.2 Preparation of 1,2-bis (5-chloro-2-methylthien-3-yl) cyclopentene
Figure PCTCN2019093093-appb-000028
Figure PCTCN2019093093-appb-000028
在氮气保护条件下,在250mL三口烧瓶中加入100mL无水四氢呋喃和锌粉(7.24g,110.71mmol),冰浴,剧烈搅拌条件下,缓慢滴加四氯化钛溶液(16.80g,88.57mmol),滴加完毕后继续冰浴搅拌5min,转移到油浴,升温至80℃,加热回流1小时,反应液颜色逐渐由黄绿色变成深黑色。自然冷却至室温,用针筒注入40mL含1,5-二(5-氯-2-甲基噻吩-3-基)戊烷-1,5-二酮)(16g,44.29mmol)的无水四氢呋喃溶液,继续加热回流4小时,停止加热,冷却后将反应液倒入10%的碳酸钾水溶液中,析出大量固体,抽滤,滤饼用无水乙醚反复洗涤,用乙醚(50mL×2)萃取水层,合并有机相,无水硫酸钠干燥过夜,过滤,旋蒸除掉溶剂,粗品用石油醚为洗脱剂,过硅胶柱,蒸干溶剂后得到无色油状液体3.3g,低温静置成无色蜡状固体,产率为30%。 1H NMR(400MHz,CDCl 3)δ6.57(s,2H),2.71(t,J=7.5Hz,4H),2.07-1.96(m,2H),1.88(s,6H). 13C NMR(101MHz,CDCl 3)δ134.82,134.41,133.28,126.67,125.18,38.32,22.81,14.16. Under nitrogen protection, 100 mL of anhydrous tetrahydrofuran and zinc powder (7.24 g, 110.71 mmol) were added to a 250 mL three-necked flask, and the titanium tetrachloride solution (16.80 g, 88.57 mmol) was slowly added dropwise under an ice bath under vigorous stirring. After completion of the dropwise addition, the ice bath was stirred for 5 min, transferred to an oil bath, heated to 80 ° C., and heated under reflux for 1 hour. The color of the reaction solution gradually changed from yellow-green to dark black. Allow to cool to room temperature, and inject 40 mL of 1,5-bis (5-chloro-2-methylthien-3-yl) pentane-1,5-dione) (16g, 44.29mmol) with a syringe. Tetrahydrofuran solution. Continue heating and refluxing for 4 hours. Stop heating. After cooling, pour the reaction solution into a 10% potassium carbonate aqueous solution, precipitate a large amount of solid, suction filter, and repeatedly filter the cake with anhydrous ether. The aqueous layer was extracted, the organic phases were combined, dried over anhydrous sodium sulfate overnight, filtered, and the solvent was removed by rotary evaporation. The crude product was eluent with petroleum ether, passed through a silica gel column, and the solvent was evaporated to give 3.3 g of a colorless oily liquid. Set to a colorless waxy solid with a yield of 30%. 1 H NMR (400 MHz, CDCl 3 ) δ 6.57 (s, 2H), 2.71 (t, J = 7.5 Hz, 4H), 2.07-1.96 (m, 2H), 1.88 (s, 6H). 13 C NMR ( 101MHz, CDCl 3 ) δ134.82,134.41,133.28,126.67,125.18,38.32,22.81,14.16.
2.3制备1,2-二(5-甲酰基-2-甲基噻吩-3-基)环戊烯2.3 Preparation of 1,2-bis (5-formyl-2-methylthien-3-yl) cyclopentene
Figure PCTCN2019093093-appb-000029
Figure PCTCN2019093093-appb-000029
在氮气及-78℃条件下,在50mL低温反应瓶中加入1,2-二(5-氯-2-甲基噻吩-3-基)环戊烯(1.50g,4.56mmol),加入10mL无水四氢呋喃,搅拌,慢慢用注射器加入2.5mol/L n-BuLi/hexane(5.5mL),继续低温搅拌反应60min,然后用预先冷却的注射器慢慢加入DMF(2.29mL),继续低温搅拌反应1h,TLC跟踪反应结束后,将反应液自然升至室温,用浓度为2M的盐酸(15mL)淬灭反应,分液,水层用无水乙醚 (20mL×2)萃取,合并有几层,然后用水洗涤三次,有机层用无水硫酸钠干燥,过滤,减压除去溶剂,将得到的粗产品用石油醚和乙酸乙醋过硅胶柱(5:1,v/v),蒸干溶剂得到1.5g蓝色固体粉末,产率为46%。 1H NMR(400MHz,CDCl 3)δ9.74(s,2H),7.43(s,2H),2.84(t,J=7.5Hz,4H),2.17-2.07(m,2H),2.05(s,6H). 13C NMR(101MHz,CDCl3)δ182.38,146.38,140.23,137.42,137.07,134.98,38.41,22.89,15.38. Under nitrogen and -78 ° C, add 1,2-bis (5-chloro-2-methylthiophen-3-yl) cyclopentene (1.50 g, 4.56 mmol) to a 50 mL low-temperature reaction flask, and add 10 mL of Water tetrahydrofuran, stir, slowly add 2.5mol / L n-BuLi / hexane (5.5mL) with a syringe, continue to stir the reaction at low temperature for 60min, then slowly add DMF (2.29mL) with a pre-cooled syringe, continue to stir at low temperature for 1h After the completion of the TLC tracking reaction, the reaction solution was naturally warmed to room temperature, and the reaction was quenched with 2M hydrochloric acid (15 mL), and the liquid was separated. The aqueous layer was extracted with anhydrous ether (20 mL × 2), and several layers were combined. It was washed three times with water, the organic layer was dried over anhydrous sodium sulfate, filtered, and the solvent was removed under reduced pressure. The obtained crude product was passed through a silica gel column (5: 1, v / v) with petroleum ether and ethyl acetate, and the solvent was evaporated to give 1.5. g blue solid powder, yield 46%. 1 H NMR (400MHz, CDCl 3 ) δ9.74 (s, 2H), 7.43 (s, 2H), 2.84 (t, J = 7.5Hz, 4H), 2.17-2.07 (m, 2H), 2.05 (s, 6H). 13 C NMR (101MHz, CDCl3) δ 182.38, 146.38, 140.23, 137.42, 137.07, 134.98, 38.41,22.89, 15.38.
2.4制备1,2-二(5-羟甲基-2-甲基噻吩-3-基)环戊烯2.4 Preparation of 1,2-bis (5-hydroxymethyl-2-methylthien-3-yl) cyclopentene
Figure PCTCN2019093093-appb-000030
Figure PCTCN2019093093-appb-000030
在氮气及冰浴条件下,在50mL圆底烧瓶中加入1,2-二(5-甲酰基-2-甲基噻吩-3-基)环戊烯(0.87g,2.75mmol),加入35mL甲醇溶解,然后分批加入硼氢化钠(0.42g,11.0mmol)。继续冰浴下搅拌反应1h,TLC跟踪反应结束后,加入适量的水淬灭反应,然后反应混合物用乙醚(30mL×2)萃取,合并有机相,有机相用饱和氯化钠溶液洗涤三次,无水硫酸钠干燥,过滤,减压除去溶剂得黄色固体,柱层析,用石油醚:乙酸乙酯=6:1(v:v)洗脱。蒸干溶剂得到白色固体0.86g,产率为98%。 1H NMR(400MHz,CDCl 3)δ6.61(s,2H),4.61(s,4H),2.75(t,J=7.4Hz,4H),2.32(s,2H),2.06-1.98(m,2H),1.95(s,6H). 13C NMR(101MHz,CDCl 3)δ139.35,135.33,134.93,134.56,126.91,59.91,38.25,22.98,14.36. Under nitrogen and ice bath conditions, in a 50 mL round-bottomed flask, add 1,2-bis (5-formyl-2-methylthiophen-3-yl) cyclopentene (0.87 g, 2.75 mmol), and 35 mL of methanol Dissolve, then add sodium borohydride (0.42 g, 11.0 mmol) in portions. The reaction was continued to be stirred in the ice bath for 1 h. After TLC followed the reaction, an appropriate amount of water was added to quench the reaction, and then the reaction mixture was extracted with diethyl ether (30 mL × 2). The organic phases were combined, and the organic phases were washed three times with saturated sodium chloride solution. It was dried over sodium sulfate, filtered, and the solvent was removed under reduced pressure to obtain a yellow solid. Column chromatography was performed with petroleum ether: ethyl acetate = 6: 1 (v: v). The solvent was evaporated to dryness to obtain 0.86 g of a white solid with a yield of 98%. 1 H NMR (400MHz, CDCl 3 ) δ6.61 (s, 2H), 4.61 (s, 4H), 2.75 (t, J = 7.4Hz, 4H), 2.32 (s, 2H), 2.06-1.98 (m, 2H), 1.95 (s, 6H ). 13 C NMR (101MHz, CDCl 3) δ139.35,135.33,134.93,134.56,126.91,59.91,38.25,22.98,14.36.
2.5制备1,2-二(5-氯甲基-2-甲基噻吩-3-基)环戊烯2.5 Preparation of 1,2-bis (5-chloromethyl-2-methylthien-3-yl) cyclopentene
Figure PCTCN2019093093-appb-000031
Figure PCTCN2019093093-appb-000031
在氮气及冰浴条件下,在100mL圆底烧瓶中加入1,2-二(5-羟甲基-2-甲基噻吩-3-基)环戊烯(0.86g,2.86mmol)和无水吡啶(1.0mL),加入40mL无水四氢呋喃溶解,搅拌。将氯化亚砜(1.28g,10.73mmol)称在恒压滴液漏斗里,慢慢滴加到反应体系中,继续冰浴搅拌反应2h。TLC跟踪反应结束后,将反应液慢慢倒入40mL冰水混合物中,搅拌。然后反应混合物用乙醚(30mL×2)萃取,合并的有机相用30mL饱和碳酸氢钠洗涤,无水硫酸钠干燥,过滤,减压除去溶剂得棕色固体。由于产物在空气中非常不稳定,所以不进行纯化立即投入下一步反应中。Under nitrogen and ice bath conditions, in a 100 mL round bottom flask, add 1,2-bis (5-hydroxymethyl-2-methylthiophen-3-yl) cyclopentene (0.86 g, 2.86 mmol) and anhydrous Pyridine (1.0 mL) was dissolved by adding 40 mL of anhydrous tetrahydrofuran and stirred. Thionyl chloride (1.28 g, 10.73 mmol) was weighed into a constant-pressure dropping funnel, slowly added to the reaction system, and the reaction was continued in an ice-bath with stirring for 2 h. After the TLC tracking reaction was completed, the reaction solution was slowly poured into a 40 mL ice-water mixture and stirred. The reaction mixture was then extracted with diethyl ether (30 mL x 2), and the combined organic phases were washed with 30 mL of saturated sodium bicarbonate, dried over anhydrous sodium sulfate, filtered, and the solvent was removed under reduced pressure to give a brown solid. Since the product was very unstable in air, it was immediately put into the next reaction without purification.
2.6制备化合物22.6 Preparation of Compound 2
Figure PCTCN2019093093-appb-000032
Figure PCTCN2019093093-appb-000032
在氮气及50℃油浴条件下,在50mL圆底烧瓶中加入氟虫腈(Fip,0.378g,1.06mmol)和碳酸铯(1.11g,2.54mmol),加入30mL二甲基甲酰胺溶解,50℃恒温搅拌反应半 个小时。然后慢慢加入用5mL二甲基甲酰胺溶解的1,2-二(5-氯甲基-2-甲基噻吩-3-基)环戊烯(0.80g,2.24mmol),继续恒温反应4h。TLC跟踪反应结束后,过滤除去沉淀物,减压除去溶剂得棕红色固体,柱层析,用乙酸乙酯:石油醚=1:5(v:v)洗脱,蒸干溶剂得到白色固体0.2g,产率为16.3%。m.p.113.4-118.5℃. 1H NMR(400MHz,DMSO)δ8.38(s,2H),8.36(s,2H),8.30(dd,J=15.0,6.4Hz,2H),6.74(d,J=7.6Hz,2H),4.57(dd,J=17.2,6.0Hz,2H),4.38-4.21(m,2H),2.68(t,J=7.2Hz,4H),1.98(dd,J=14.4,7.2Hz,2H),1.80(d,J=8.0Hz,6H). 13C NMR(101MHz,DMSO)δ149.68,136.09,135.91,135.76,134.98,134.26,133.71,126.92,126.10,125.49,123.55,120.79,111.37,95.13,90.7,30.92,22.04,13.96. 19F NMR(376MHz,CDCl 3)δ-62.10--64.26(m),-73.19--75.35(m).HRMS(ESI-TOF):m/z C 41H 24 35Cl 4F 12N 8O 2S 4Na[M+Na] +计算值:1178.9365,实测值:1178.9355;m/z C 41H 24 35Cl 3 37ClF 12N 8O 2S 4Na[M+Na] +计算值:1180.9336,实测值:1180.9349;m/z C 41H 24 35Cl 2 37Cl 2F 12N 8O 2S 4Na[M+Na] +计算值:1182.9306,实测值:1182.9320;m/z C 41H 24 35Cl 37Cl 3F 12N 8O 2S 4Na[M+Na] +计算值:1184.9277,实测值:1184.9261;m/z C 41H 24 37Cl 4F 12N 8O 2S 4Na[M+Na] +计算值:1186.9247,实测值:1186.9230. Under nitrogen and 50 ° C oil bath conditions, put fipronil (Fip, 0.378 g, 1.06 mmol) and cesium carbonate (1.11 g, 2.54 mmol) in a 50 mL round bottom flask, add 30 mL of dimethylformamide to dissolve, 50 The reaction was stirred at a constant temperature of ℃ for half an hour. Then slowly add 1,2-bis (5-chloromethyl-2-methylthien-3-yl) cyclopentene (0.80 g, 2.24 mmol) dissolved in 5 mL of dimethylformamide, and continue the reaction at constant temperature for 4 h . After the completion of the TLC tracking reaction, the precipitate was removed by filtration, and the solvent was removed under reduced pressure to obtain a brown-red solid. Column chromatography was eluted with ethyl acetate: petroleum ether = 1: 5 (v: v). The solvent was evaporated to give a white solid 0.2. g, yield 16.3%. mp113.4-118.5 ℃. 1 H NMR (400MHz, DMSO) δ 8.38 (s, 2H), 8.36 (s, 2H), 8.30 (dd, J = 15.0, 6.4 Hz, 2H), 6.74 (d, J = 7.6Hz, 2H), 4.57 (dd, J = 17.2, 6.0Hz, 2H), 4.38-4.21 (m, 2H), 2.68 (t, J = 7.2Hz, 4H), 1.98 (dd, J = 14.4, 7.2Hz, 2H), 1.80 (d, J = 8.0Hz, 6H). 13 C NMR (101MHz, DMSO) δ149.68, 136.09, 135.91, 135.76, 134.98, 134.26, 133.71, 126.92, 126.10, 125.49, 123.55, 120.79, 111.37, 95.13, 90.7, 30.92, 22.04, 13.96. 19 F NMR (376MHz, CDCl 3 ) δ-62.10--64.26 (m), -73.19--75.35 (m) .HRMS (ESI-TOF): m / z C 41 H 24 35 Cl 4 F 12 N 8 O 2 S 4 Na [M + Na] + Calculated: 1178.9365, Found: 1178.9355; m / z C 41 H 24 35 Cl 3 37 ClF 12 N 8 O 2 S 4 Na [M + Na] + Calculated: 1180.9336, Found: 1180.9349; m / z C 41 H 24 35 Cl 2 37 Cl 2 F 12 N 8 O 2 S 4 Na [M + Na] + Calculated: 1182.9306 , Found: 1182.9320; m / z C 41 H 24 35 Cl 37 Cl 3 F 12 N 8 O 2 S 4 Na [M + Na] + Calculated: 1184.9277, Found: 1184.9261; m / z C 41 H 24 37 Cl 4 F 12 N 8 O 2 S 4 Na [M + Na] + Calculated: 1186.9247, Found: 1186.9230.
制备N-甲基氟虫腈Preparation of N-methyl fipronil
Figure PCTCN2019093093-appb-000033
Figure PCTCN2019093093-appb-000033
将N-(3-氰基-1-(2,6-二氯-4-(三氟甲基)苯基)-4-((三氟甲基)亚磺酰基)-1H-吡唑-5-基)丙酰胺(4.91g,10mmol),20mmol稀硫酸在乙醇中搅拌,100℃下反应,TLC跟踪反应至反应结束。水洗,调pH,萃取反应液,由于得到产物较纯,无需纯化直接投下一步。N- (3-cyano-1- (2,6-dichloro-4- (trifluoromethyl) phenyl) -4-((trifluoromethyl) sulfinyl) -1H-pyrazole- 5-yl) propionamide (4.91 g, 10 mmol), 20 mmol of dilute sulfuric acid was stirred in ethanol, and the reaction was carried out at 100 ° C. The reaction was followed by TLC to the end of the reaction. Wash with water, adjust the pH, and extract the reaction solution. Because the product obtained is relatively pure, it is directly sent to the next step without purification.
制备化合物3Preparation of compound 3
Figure PCTCN2019093093-appb-000034
Figure PCTCN2019093093-appb-000034
合成方法同化合物2,步骤2.6,不同点在于,用N-甲基基氟虫腈替换氟虫腈。The synthesis method is the same as that of compound 2, step 2.6, except that the fipronil is replaced by N-methyl fipronil.
m.p.118.2-123.1℃. 1H NMR(400MHz,DMSO)δ7.55(s,2H),7.56(s,2H),6.58(d,J=7.6Hz,2H),4.58(dd,J=17.2,6.0Hz,2H),4.57-4.21(m,2H),2.38(t,J=7.2Hz,4H),2.33(s,6H),1.88(dd,J=14.4,7.2Hz,2H),1.11(t,J=8.0Hz,6H). 13C NMR(101MHz,DMSO)δ 154.78,141.38,139.09,136.91,135.28,134.76,133.98,131.22,130.11,127.26,125.71,123.92,123.10,115.49,110.37,55.13,46.78,30.92,21.04,12.78.HRMS(ESI-TOF):m/z C 43H 28 35Cl 4F 12N 8O 2S 4Na[M+Na] +计算值:1206.9678,实测值:1206.9675C 43H 28 35Cl 3 37ClF 12N 8O 2S 4Na[M+Na] +计算值:1208.9649,实测值:1208.9645;m/z C 43H 28 35Cl 2 37Cl 2F 12N 8O 2S 4Na[M+Na] +计算值:1210.9619,实测值:1210.9616;m/z C 43H 28 35Cl 37Cl 3F 12N 8O 2S 4Na[M+Na] +计算值:1212.9590,实测值:1212.9577;m/z C 43H 28 37Cl 4F 12N 8O 2S 4Na[M+Na] +计算值:1214.9548,实测值:1214.9553. mp118.2-123.1 ℃. 1 H NMR (400MHz, DMSO) δ 7.55 (s, 2H), 7.56 (s, 2H), 6.58 (d, J = 7.6 Hz, 2H), 4.58 (dd, J = 17.2 , 6.0Hz, 2H), 4.57-4.21 (m, 2H), 2.38 (t, J = 7.2Hz, 4H), 2.33 (s, 6H), 1.88 (dd, J = 14.4, 7.2Hz, 2H), 1.11 (t, J = 8.0Hz, 6H). 13 C NMR (101MHz, DMSO) δ 154.78,141.38,139.09,136.91,135.28,134.76,133.98,131.22,130.11,127.26,125.71,123.92,123.10,115.49,110.37, 55.13, 46.78, 30.92, 21.04, 12.78. HRMS (ESI-TOF): m / z C 43 H 28 35 Cl 4 F 12 N 8 O 2 S 4 Na [M + Na] + Calculated value: 1206.9678, Found: 1206.9675C 43 H 28 35 Cl 3 37 ClF 12 N 8 O 2 S 4 Na [M + Na] + Calculated: 1208.9649, Found: 1208.9645; m / z C 43 H 28 35 Cl 2 37 Cl 2 F 12 N 8 O 2 S 4 Na [M + Na] + Calculated: 1210.9619, Found: 1210.9616; m / z C 43 H 28 35 Cl 37 Cl 3 F 12 N 8 O 2 S 4 Na [M + Na] + Calculated Value: 1212.9590, Found: 1212.9577; m / z C 43 H 28 37 Cl 4 F 12 N 8 O 2 S 4 Na [M + Na] + Calculated: 1214.9548, Found: 1214.9553.
制备化合物4Preparation of compound 4
Figure PCTCN2019093093-appb-000035
Figure PCTCN2019093093-appb-000035
合成方法同化合物1,步骤1.7;不同点在于,用N-甲基基氟虫腈替换氟虫腈。The synthetic method is the same as that of compound 1, step 1.7; the difference is that fipronil is replaced by N-methyl fipronil.
m.p.121.8-124.3℃. 1H NMR(400MHz,DMSO)δ7.58(s,2H),7.57(s,2H),6.68(d,J=7.6Hz,2H),4.88(dd,J=17.2,6.0Hz,2H),4.87-4.51(m,2H),2.45(s,6H),1.21(t,J=8.0Hz,6H). 13C NMR(101MHz,DMSO)δ156.78,143.38,142.09,139.12,136.71,135.10,134.16,133.98,131.02,127.56,125.88,123.16,122.49,114.23,109.03,107.11,58.88,55.13,47.78,12.28.HRMS(ESI-TOF):m/z C 43H 22 35Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1314.9113,实测值:1314.9110;C 43H 22 35Cl 3 37ClF 18N 8O 2S 4Na[M+Na] +计算值:1316.9083,实测值:1316.9080;m/z C 43H 22 35Cl 2 37Cl 2F 18N 8O 2S 4Na[M+Na] +计算值:1318.9041.实测值:1318.9044;m/z C 43H 22 35Cl 37Cl 3F 18N 8O 2S 4Na[M+Na] +计算值:1320.9121,实测值:1320.9117;m/z C 43H 22 37Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1322.8982,实测值:1322.8985. mp121.8-124.3 ℃. 1 H NMR (400MHz, DMSO) δ 7.58 (s, 2H), 7.57 (s, 2H), 6.68 (d, J = 7.6 Hz, 2H), 4.88 (dd, J = 17.2 , 6.0Hz, 2H), 4.87-4.51 (m, 2H), 2.45 (s, 6H), 1.21 (t, J = 8.0Hz, 6H). 13 C NMR (101MHz, DMSO) δ 156.78, 143.38, 142.09, 139.12 , 136.71,135.10,134.16,133.98,131.02,127.56,125.88,123.16,122.49,114.23,109.03,107.11,58.88,55.13,47.78,12.28.HRMS (ESI-TOF): m / z C 43 H 22 35 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated value: 1314.9113, Found: 1314.9110; C 43 H 22 35 Cl 3 37 ClF 18 N 8 O 2 S 4 Na [M + Na] + Calculated value : 1316.9083, found: 1316.9080; m / z C 43 H 22 35 Cl 2 37 Cl 2 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1318.9041. Found: 1318.9044; m / z C 43 H 22 35 Cl 37 Cl 3 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1320.9121, Found: 1320.9117; m / z C 43 H 22 37 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1322.8982, Found: 1322.8985.
制备N-丁基氟虫腈Preparation of N-butyl fipronil
Figure PCTCN2019093093-appb-000036
Figure PCTCN2019093093-appb-000036
向超声波喷雾器中(固定功率150W)中加入50mlN,N-二甲基甲酰胺、10.0g氟虫腈、2g KOH,再加入2.7g正溴丁烷,室温下超声震动一小时,震荡完毕打开喷雾开关,通过气管把雾气送入微波反应器顶部,打开微波反应器,功率调节到300W开始加热反应,当超声波喷雾器中溶剂快要雾化干时(现象是连接超声波喷雾器与微波反应器的透明导管 中雾气明显减少),停止雾化,关闭微波反应器的进样口,继续反应120min.反应完后产物经水洗,过滤干燥后得11.6g化合物。收率92.6%. 1H NMR(400MHz,CDCl 3)δ7.90(s,1H),7.80(s,1H),5.62(s,2H),2.82(s,2H),2.52(s,2H),2.02(s,2H),1.52(s,1H). Add 50ml N, N-dimethylformamide, 10.0g fipronil, 2g KOH to the ultrasonic sprayer (fixed power 150W), and then add 2.7g n-bromobutane. The ultrasonic vibration is performed at room temperature for one hour, and the spray is opened after shaking. The switch sends the mist to the top of the microwave reactor through the air pipe. The microwave reactor is turned on and the power is adjusted to 300W to start the heating reaction. When the solvent in the ultrasonic sprayer is about to be atomized and dried (the phenomenon is in the transparent tube connecting the ultrasonic sprayer and the microwave reactor The mist was significantly reduced), the atomization was stopped, the sample inlet of the microwave reactor was closed, and the reaction was continued for 120 minutes. After the reaction, the product was washed with water, and 11.6 g of the compound was obtained after filtering and drying. Yield 92.6%. 1 H NMR (400MHz , CDCl 3) δ7.90 (s, 1H), 7.80 (s, 1H), 5.62 (s, 2H), 2.82 (s, 2H), 2.52 (s, 2H) , 2.02 (s, 2H), 1.52 (s, 1H).
制备化合物5Preparation of compound 5
Figure PCTCN2019093093-appb-000037
Figure PCTCN2019093093-appb-000037
合成方法同化合物1,步骤1.7;不同点在于,用N-丁基氟虫腈替换氟虫腈。The synthesis method is the same as that of compound 1, step 1.7; the difference is that fipronil is replaced with N-butyl fipronil.
m.p.151.4-154.7℃. 1H NMR(400MHz,DMSO)δ7.85(s,2H),7.87(s,2H),6.69(d,J=7.6Hz,2H),4.98(dd,J=17.2,6.0Hz,2H),4.87-4.41(m,2H),3.51(m,4H),3.40(m,4H),3.21(m,4H)2.45(s,6H),1.01(t,J=8.0Hz,6H). 13C NMR(101MHz,DMSO)δ165.88,142.38,141.09,139.82,136.11,135.29,135.00,134.78,131.32,127.59,125.69,123.66,123.06,122.21,115.23,108.03,107.61,61.22,57.88,30.87,27.21,21.78,15.06,11.28.HRMS(ESI-TOF):m/z C 49H 34 35Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1399.0052,实测值:1399.0056;C 49H 34 35Cl 3 37ClF 18N 8O 2S 4Na[M+Na] +计算值:1401.0022,实测值:1401.0020;m/z C 49H 34 35Cl 2 37Cl 2F 18N 8O 2S 4Na[M+Na] +计算值:1403.0090,实测值:1403.0087;m/z C 49H 34 35Cl 37Cl 3F 18N 8O 2S 4Na[M+Na] +计算值:1405.0047,实测值:1405.0050;m/z C 49H 34 37Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1407.0031,实测值:1407.0030. mp151.4-154.7 ℃. 1 H NMR (400MHz, DMSO) δ 7.85 (s, 2H), 7.87 (s, 2H), 6.69 (d, J = 7.6 Hz, 2H), 4.98 (dd, J = 17.2 , 6.0Hz, 2H), 4.87-4.41 (m, 2H), 3.51 (m, 4H), 3.40 (m, 4H), 3.21 (m, 4H) 2.45 (s, 6H), 1.01 (t, J = 8.0 Hz, 6H). 13 C NMR (101MHz, DMSO) δ165.88,142.38,141.09,139.82,136.11,135.29,135.00,134.78,131.32,127.59,125.69,123.66,123.06,122.21,115.23,108.03,107.61,61.22,57.88 , 30.87,27.21,21.78,15.06,11.28.HRMS (ESI-TOF): m / z C 49 H 34 35 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated value: 1399.0052, found : 1399.0056; C 49 H 34 35 Cl 3 37 ClF 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1401.0022, Found: 1401.0020; m / z C 49 H 34 35 Cl 2 37 Cl 2 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1403.0090, Found: 1403.0087; m / z C 49 H 34 35 Cl 37 Cl 3 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1405.0047, Found: 1405.0050; m / z C 49 H 34 37 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1407.0031, Found: 1407.0030.
制备化合物6Preparation of compound 6
Figure PCTCN2019093093-appb-000038
Figure PCTCN2019093093-appb-000038
合成方法同化合物1,步骤1.7;在氮气及50℃油浴条件下,在50mL圆底烧瓶中加入N-甲基氟虫腈(0.202g,0.45mmol)、N-丁基氟虫腈(0.221g,0.45mmol)和碳酸铯(0.949g,2.17mmol),加入30mL二甲基甲酰胺溶解,50℃恒温搅拌反应半个小时。然后慢慢加入用5mL二甲基甲酰胺溶解的1,2-二(2-甲基-5-氯甲基-3-噻吩基)八氟环戊烯,继续恒温反应4h。TLC跟踪反应结束后,过滤除去沉淀物,减压除去溶剂得棕红色固体,柱层析,用乙酸乙酯:石油醚=1:5(v:v)洗脱,蒸干溶剂得到白色固体0.20g,产率为16.2%。The synthesis method is the same as that of compound 1, step 1.7. Under nitrogen and 50 ° C oil bath conditions, a 50 mL round bottom flask was charged with N-methyl fipronil (0.202 g, 0.45 mmol) and N-butyl fipronil (0.221). g, 0.45 mmol) and cesium carbonate (0.949 g, 2.17 mmol), dissolved by adding 30 mL of dimethylformamide, and stirred at 50 ° C for half an hour under constant temperature stirring. Then slowly add 1,2-bis (2-methyl-5-chloromethyl-3-thienyl) octafluorocyclopentene dissolved in 5 mL of dimethylformamide, and continue the reaction at constant temperature for 4 h. After the completion of the TLC tracking reaction, the precipitate was removed by filtration, and the solvent was removed under reduced pressure to obtain a brown-red solid. Column chromatography was eluted with ethyl acetate: petroleum ether = 1: 5 (v: v). The solvent was evaporated to give a white solid 0.20 g, yield 16.2%.
m.p.181.1-189.5℃. 1H NMR(400MHz,DMSO)δ7.57(s,2H),7.45(s,2H),6.58(d,J=7.6Hz,1H),6.57(d,J=7.6Hz,1H),4.58(dd,J=17.2,6.0Hz,2H),4.57-4.11(m,2H),3.41(m,2H),3.01(s,3H),2.47(s,3H),2.48(s,3H),2.21(m,2H),2.11(m,2H),1.11(t,J=8.0Hz,3H). 13C NMR(101MHz,DMSO)δ165.05,155.21,143.33,142.23,141.01,139.88,138.88,136.71,137.14,135.33,134.34,133.99,132.01,131.46,128.87,127.86,126.54,125.88,124.33,123.56,123.01,122.11,120.98,120.03,117.21,115.74,114.49,112.45,111.94,111.65,109.52,107.81,62.31,59.91,48.76,47.32,39.21,30.21,27.34,23.44,15.23,12.89.HRMS(ESI-TOF):m/z C 46H 28 35Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1356.9582,实测值:1356.9583;C 46H 28 35Cl 3 37ClF 18N 8O 2S 4Na[M+Na] +计算值:1358.9553,实测值:1358.9556;m/z C 46H 28 35Cl 2 37Cl 2F 18N 8O 2S 4Na[M+Na] +计算值:1360.9511,实测值:1360.9516;m/z C 46H 28 35Cl 37Cl 3F 18N 8O 2S 4Na[M+Na] +计算值:1362.9494,实测值:1362.9490;m/z C 46H 28 37Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1364.9452,实测值:1364.9450. mp181.1-189.5 ℃. 1 H NMR (400MHz, DMSO) δ 7.57 (s, 2H), 7.45 (s, 2H), 6.58 (d, J = 7.6 Hz, 1H), 6.57 (d, J = 7.6 Hz, 1H), 4.58 (dd, J = 17.2, 6.0 Hz, 2H), 4.57-4.11 (m, 2H), 3.41 (m, 2H), 3.01 (s, 3H), 2.47 (s, 3H), 2.48 (s, 3H), 2.21 ( m, 2H), 2.11 (m, 2H), 1.11 (t, J = 8.0Hz, 3H). 13 C NMR (101MHz, DMSO) δ165.05,155.21,143.33,142.23,141.01, 139.88,138.88,136.71,137.14,135.33,134.34,133.99,132.01,131.46,128.87,127.86,126.54,125.88,124.33,123.56,123.01,122.11,120.98,120.03,117.21,115.74,114.49,112.45,111.94,111.94 109.52, 107.81, 62.31, 59.91, 48.76, 47.32, 39.21, 30.21, 27.34, 23.44, 15.23, 12.89. HRMS (ESI-TOF): m / z C 46 H 28 35 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1356.9582, Found: 1356.9583; C 46 H 28 35 Cl 3 37 ClF 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1358.9553, Found: 1358.9556; m / z C 46 H 28 35 Cl 2 37 Cl 2 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1360.9511, Found: 1360.9516; m / z C 46 H 28 35 Cl 37 Cl 3 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1362.9494, Found: 1362.9490; m / z C 46 H 28 37 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated Value: 1364 .9452, Found: 1364.9450.
制备化合物7Preparation of compound 7
Figure PCTCN2019093093-appb-000039
Figure PCTCN2019093093-appb-000039
合成方法同化合物6;不同点在于,用氟虫腈替换N-丁基氟虫腈。The synthetic method is the same as that of compound 6; the difference is that N-butyl fipronil is replaced with fipronil.
m.p.195.8-209.6℃. 1H NMR(400MHz,DMSO)δ7.67(s,2H),7.55(s,2H),6.59(d,J=7.6Hz,1H),6.61(d,J=7.6Hz,1H),5.11(d,J=17.2,1H),4.68(dd,J=17.2,6.0Hz,2H),4.77-4.31(m,2H),3.21(s,3H),2.17(s,3H),2.18(s,3H) 13C NMR(101MHz,DMSO)δ158.78,155.34,145.65,144.21,142.56,141.31,139.80,138.87,137.21,136.77,135.26,135.11,134.21,133.87,131.29,129.87,128.66,127.61,127.06,126.34,125.78,124.11,123.54,123.07,122.43,122.06,120.87,114.21,112.87,110.98,109.33,108.64,107.26,62.34,47.87,40.26,39.11,15.23.HRMS(ESI-TOF):m/z C 42H 20 35Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1300.8956,实测值:1300.8954;C 42H 20 35Cl 3 37ClF 18N 8O 2S 4Na[M+Na] +计算值:1302.8927,实测值:1302.8931;m/z C 42H 20 35Cl 2 37Cl 2F 18N 8O 2S 4Na[M+Na] +计算值:1304.8897,实测值:1304.8890;m/z C 42H 20 35Cl 37Cl 3F 18N 8O 2S 4Na[M+Na] +计算值:1306.8868,实测值:1306.8870;m/z C 42H 20 37Cl 4F 18N 8O 2S 4Na[M+Na] +计算值:1308.8826,实测值:1308.8823. mp195.8-209.6 ℃. 1 H NMR (400MHz, DMSO) δ 7.67 (s, 2H), 7.55 (s, 2H), 6.59 (d, J = 7.6 Hz, 1H), 6.61 (d, J = 7.6 Hz, 1H), 5.11 (d, J = 17.2, 1H), 4.68 (dd, J = 17.2, 6.0 Hz, 2H), 4.77-4.31 (m, 2H), 3.21 (s, 3H), 2.17 (s, 3H), 2.18 (s, 3H) 13 C NMR (101MHz, DMSO) δ158.78,155.34,145.65,144.21,142.56,141.31,139.80,138.87,137.21,136.77,135.26,135.11,134.21,133.87,131.29,129.87,128.66 , 127.61,127.06,126.34,125.78,124.11,123.54,123.07,122.43,122.06,120.87,114.21,112.87,110.98,109.33,108.64,107.26,62.34,47.87,40.26,39.11,15.23.HRMS (ESI-TOF): m / z C 42 H 20 35 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1300.8956, Found: 1300.8954; C 42 H 20 35 Cl 3 37 ClF 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1302.8927, Found: 1302.8931; m / z C 42 H 20 35 Cl 2 37 Cl 2 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1304.8897 , Found: 1304.8890; m / z C 42 H 20 35 Cl 37 Cl 3 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1306.8868, Found: 1306.8870; m / z C 42 H 20 37 Cl 4 F 18 N 8 O 2 S 4 Na [M + Na] + Calculated: 1308.8826, Found: 1308.8823.
实施例3本发明化合物的杀虫活性测试Example 3 Insecticide activity test of the compound of the present invention
(1)对蚜虫的杀虫活性(1) Insecticidal activity against aphids
蚜虫俗称腻虫或蜜虫等,属于同翅目害虫,是一种常见的农作物害虫。蚜虫主要分布在北半球温带地区和亚热带地区,热带地区分布很少。蚜虫为刺吸式口器的害虫,常群集于叶片、嫩茎、花蕾、顶芽等部位,刺吸汁液,使叶片皱缩、卷曲、畸形,严 重时引起枝叶枯萎甚至整株死亡。蚜虫分泌的蜜露还会诱发煤污病、病毒病并招来蚂蚁危害等。蚜虫繁殖和适应力强,各种防治方法都很难取得根治的效果。对于蚜虫防治,重要的是抓紧防治,避免蚜虫大量发生。以豆蚜(Aphis craccivora)为测试对象,采用浸渍法测试。Aphids are commonly known as greasy or honey bugs, belonging to the homoptera order, and are a common crop pest. Aphids are mainly distributed in temperate and subtropical regions of the northern hemisphere, and they are rarely distributed in tropical regions. Aphids are pests of stinging mouthparts, often clustering in leaves, tender stems, flower buds, and top buds, etc., sucking juice, causing the leaves to shrink, curl, and deform, causing severe withering or even death of the entire plant. Honeydew secreted by aphids can also cause coal pollution, virus disease and attract ants. Aphids have strong reproduction and adaptability, and various control methods are difficult to achieve a curative effect. For the control of aphids, it is important to control them to prevent aphids from occurring in large numbers. Bean aphid (Aphis craccivora) was used as a test object, and the test was performed by dipping method.
操作过程:选取健壮的豆蚜无翅成虫(虫体呈黑绿色,有光泽,腹部饱满。各足褪节、胫节、跗节均暗黑色,其余部分黄白色)若干。避光,在黑暗条件下饥饿处理0.5~1h。选取长势良好,高约3cm的蚕豆豆苗,洗去沙土(注意尽量保持豆皮完整),掐去豆根,插入带水海绵上,使豆苗保持水分供给的充足。将经过饥饿处理的豆蚜抖落在豆苗周围,在阳光下让蚜虫爬苗,并刺入口针(耗时约2~3h),最终使每棵豆苗爬有蚜虫约20~30头。配制所需浓度的化合物溶液,分为两组,第一组不经紫外光的照射(未光照组),第二组用310nm紫外灯照射一定的时间(光照组,放在黑暗条件下),溶液中DMSO含量不超过5%,溶液中含有少量表面活性剂剂曲拉通(500ml清水中含曲拉通2~3滴)。采用浸苗法处理蚜虫,将爬有豆蚜的豆苗在已配好的两组溶液中浸泡2~3s,连续3次。然后用吸水纸吸干豆苗上多余的溶液,每个浓度3个重复。然后将豆苗插入带水海绵上,罩上马灯罩,避光,在25℃恒温条件下放置48h。48h后观察并统计光照组和未光照组蚜虫死亡情况,并根据公式计算死亡率(%):死亡率(%)=(对照活虫数-处理活虫数)/对照活虫数×100%。结果见表1。Operation process: Select robust bean aphid wingless adults (the worm body is black-green, shiny, and the abdomen is full. The fading, tibia, and pupa of each foot are dark black, and the rest are yellow-white). Protect from light and starve for 0.5 to 1 h in the dark. Select broad bean seedlings with a good growth, about 3cm in height, wash the sand (take care to keep the bean skin intact), remove the roots, insert them into a sponge with water, so that the bean seedlings maintain sufficient water supply. The starved bean aphids were shaken around the bean seedlings, and the aphids were allowed to climb the seedlings in the sun, and punctured the needles (which took about 2 to 3 hours), and finally each bean seedling was crawled with about 20 to 30 aphids. The compound solution with the required concentration was prepared and divided into two groups. The first group was not irradiated with ultraviolet light (unlighted group), and the second group was irradiated with 310nm ultraviolet light for a certain period of time (lighted group, placed in dark conditions). The content of DMSO in the solution does not exceed 5%, and the solution contains a small amount of the surfactant Tritraton (2 to 3 drops of Tritraton in 500ml of water). The aphids are treated by the seed soaking method, and the bean seedlings crawling with the bean aphids are immersed in the prepared two groups of solutions for 2 to 3 s for three consecutive times. Then use blotting paper to blot the excess solution from the bean sprouts, in triplicate for each concentration. Then insert the bean sprouts into a sponge with water, put on a horse light cover, protect from light, and leave it at 25 ° C for 48 hours. After 48 hours, observe and count the death of aphids in the light group and the non-light group, and calculate the mortality rate (%) according to the formula: mortality rate (%) = (control live insects-treated live insects) / control live insects × 100% . The results are shown in Table 1.
(2)对白纹伊蚊4龄幼虫的杀虫活性(2) Insecticidal activity against 4th instar larvae of Aedes albopictus
白纹伊蚊(Aedes albopictus)俗称黑蚊子、花蚊子、花斑蚊、花脚蚊,生性凶猛、攻击力强,也被称为"亚洲虎蚊",属于长角亚目蚊科,中等大小的黑色蚊虫,上面具有白色鳞片形成的斑纹,白纹伊蚊源于东南亚,是东南亚和中国的常见蚊种。白纹伊蚊幼虫(孑孓)无脊椎动物,昆虫纲,双翅目蚊类的幼虫。它是由雌蚊在淡水中产的卵孵化而成,其体细长,胸部较头部及腹部宽大,游泳时身体一屈一伸,通称跟头虫。白纹伊蚊喜欢在小面积的积水上产卵,而且其幼虫具有"嗜静"的特性。水环境安静、阴凉,不易受打扰,最适合这种伊蚊产卵以及孑孓存活。孑孓身体细长,呈深褐色,在水中上下垂直游动,以水中的细菌和单细胞藻类为食,呼吸空气。幼虫主要孳生于人房附近的竹筒、树洞、石穴、废轮胎以及缸罐、瓦钵、泡菜缸等容器积水,也见于菠萝等植物叶腋。孑孓经4次蜕皮后发育成蛹,初期蛹仍可活动,将羽化时则基本不可动,而后羽化为成蚊。白纹伊蚊既是一种攻击性很强的蚊子,也是一种重要的病毒媒介,它可以传播很多病原体,包括登革热、罗斯河病毒和西尼罗病毒。蚊虫的综合治理方法包括环境治理、生物防治、化学防治、法规防治和遗传防治等。化学防治是通过对孳生地投药,对白纹伊蚊的成蚊直接喷洒起到了较好作用,但是在投入较大的人力、物力、财力的同时对环境造成了不同程度的污染,化学药物的应用也使蚊虫产生抗药性。因此研究高效、低毒的杀虫剂来杀灭蚊子的幼虫,可以有效的控制蚊子数量的增加,抑制人类疾病的传播。Aedes albopictus is commonly known as black mosquito, flower mosquito, spotted mosquito, flower foot mosquito, fierce and aggressive, also known as "Asian tiger mosquito", belonging to the family Aceridae, medium size Black mosquitoes with markings formed by white scales. Aedes albopictus originated from Southeast Asia and is a common mosquito species in Southeast Asia and China. Aedes albopictus larvae (pupa) invertebrates, insects, larvae of Diptera. It is hatched from eggs laid by female mosquitoes in fresh water. Its body is slender, its chest is wider than its head and abdomen, and its body flexes and stretches when swimming. Aedes albopictus likes to lay eggs on a small area of standing water, and its larvae are "quiet". The water environment is quiet and shady, and it is not easy to be disturbed.孑孓 The body is slender and dark brown, swimming vertically in the water, feeding on bacteria and unicellular algae in the water, and breathing air. Larvae mainly accumulate water in bamboo tubes, tree holes, stone caves, waste tires, and tanks, earthenware bowls, and pickle tanks near the human house. They are also found in the leaf axils of plants such as pineapples. The tadpoles develop into tadpoles after 4 molts. The tadpoles can still move in the early stage, but they are basically immobile when they emerge, and then become mosquitoes. Aedes albopictus is both a highly aggressive mosquito and an important viral vector. It can transmit many pathogens, including dengue, Ross River virus, and West Nile virus. Comprehensive mosquito control methods include environmental control, biological control, chemical control, regulatory control and genetic control. The chemical control is through the injection of the breeding ground, which has a good effect on the direct spraying of Aedes albopictus adult mosquitoes, but it has caused considerable pollution to the environment while investing a large amount of human, material and financial resources, and the application of chemical drugs It also makes mosquitoes resistant. Therefore, research on high-efficiency, low-toxic insecticides to kill mosquito larvae can effectively control the increase in the number of mosquitoes and inhibit the spread of human diseases.
操作过程:选取大小一致的4龄白纹伊蚊幼虫若干。将待测化合物以DMSO助溶(溶 液中DMSO含量不超过5%),用除氯水稀释,准确配制成800、400、200、100、50、25、12.5、6.25、3.13、1.57ppm溶液,设置两组实验,第一组不经紫外光的照射(未光照组),第二组用310nm紫外灯照射一定的时间(光照组,放在黑暗条件下)。然后取配制好的各浓度的化合物2mL加入到4mL的离心管中,再分别转移30只孑孓进入相应的离心管,最后补加2mL的除氯水,使溶液体积为4mL,最终化合物浓度为400、200、100、50、25、12.5、6.25、3.13、1.57、0.79ppm,并以除氯水溶液处理作空白对照,以吡虫啉作为阳性对照,每个浓度设3个重复。将光照组和未光照组都放入黑暗条件下,在25℃恒温条件下放置24h。24h后观察并统计光照组和未光照组孑孓死亡情况,并根据公式计算死亡率(%):死亡率(%)=(对照活虫数-处理活虫数)/对照活虫数×100%。结果见表1。Operation process: Select a few 4th instar Aedes albopictus larvae with the same size. Dilute the test compound with DMSO (the content of DMSO in the solution does not exceed 5%), dilute it with dechlorinated water, and accurately prepare 800, 400, 200, 100, 50, 25, 12.5, 6.25, 3.13, 1.57ppm solutions. Two sets of experiments were set up, the first group was not irradiated with ultraviolet light (unlighted group), and the second group was irradiated with 310nm ultraviolet light for a certain time (lighted group, placed in dark conditions). Then take 2 mL of the compound of each concentration and add it to a 4 mL centrifuge tube, and then transfer 30 maggots into the corresponding centrifuge tube. Finally, add 2 mL of dechlorinated water to make the solution volume 4 mL, and the final compound concentration is 400. , 200, 100, 50, 25, 12.5, 6.25, 3.13, 1.57, 0.79 ppm, and treated with a chlorine-free aqueous solution as a blank control, and imidacloprid as a positive control, each concentration was set up in triplicate. Both the light group and the non-light group were placed in a dark condition, and left at a constant temperature of 25 ° C for 24 hours. After 24 hours, observe and count the death of the maggots in the light group and the non-light group, and calculate the mortality rate (%) according to the formula: mortality rate (%) = (control live insects-treated live insects) / control live insects × 100% . The results are shown in Table 1.
表1.式(A)化合物的杀虫活性Table 1. Insecticidal activity of compounds of formula (A)
Figure PCTCN2019093093-appb-000040
Figure PCTCN2019093093-appb-000040
实施例4化合物1的光致变色现象Example 4 Photochromism of Compound 1
光致变色现象(photochromism)是指化合物A,在受到特定波长光照射后,能够 进行特定的化学反应,进而生成产物B,而在另一波长光照射或者热的作用下,又可恢复到原来的状态的现象。Photochromism refers to compound A, which can undergo a specific chemical reaction after being irradiated with light of a specific wavelength, thereby producing product B, and can be restored to the original under the action of light of another wavelength of light or heat. State of the phenomenon.
二芳基乙烯类化合物也是一类基于周环反应的有机光致变色化合物。此类化合物的母体结构是一个6π电子共轭的己三烯。在紫外光激发下,处于反平行状态的分子发生分子内的顺旋关环反应,形成共轭的闭环态分子而呈色。而在可见光的照射后,闭环态分子开环恢复至原来状态。经过适当的分子结构修饰,此类化合物的闭环态可以呈现出从黄色到绿色的全部颜色。Diarylvinyl compounds are also a class of organic photochromic compounds based on pericyclic reactions. The parent structure of these compounds is a 6π electron-conjugated hexatriene. Under the excitation of ultraviolet light, molecules in antiparallel state undergo an intramolecular cyclotron ring-closing reaction to form a conjugated closed-loop molecule and appear colored. After irradiation with visible light, the closed-loop molecules return to the original state. After proper molecular structure modification, the closed-loop state of such compounds can show all colors from yellow to green.
以化合物1为例说明:化合物1在紫外光的作用下发生了闭环的光致变色反应,反应式如下:Take Compound 1 as an example to illustrate: Compound 1 undergoes a photochromic reaction in a closed loop under the action of ultraviolet light. The reaction formula is as follows:
Figure PCTCN2019093093-appb-000041
Figure PCTCN2019093093-appb-000041
采用310nm的紫外光照射开环化合物1的乙腈溶液,开环化合物1慢慢形成关环化合物1,在可见光区520nm处出现一个很宽的吸收峰,且随着照射时间的延长,关环产物浓度逐渐增大,吸收峰的强度逐渐增强。大约经过90s照射后,化合物1达到开环闭环的平衡态(图1),可以观察到溶液的颜色很快由无色变为红色,这说明化合物1在紫外光的作用下发生了闭环的光致变色反应。然后用493nm的蓝光照射关环化合物1,可以观察到溶液颜色由红色变为无色,说明关环化合物1在可见光下发生了开环的光致变色反应。The acetonitrile solution of ring-opening compound 1 was irradiated with ultraviolet light at 310 nm. The ring-opening compound 1 slowly formed ring-closed compound 1. A broad absorption peak appeared at 520 nm in the visible light region. With the extension of the irradiation time, the ring-closed product As the concentration increases, the intensity of the absorption peak increases. After about 90s of irradiation, compound 1 reached the equilibrium state of open-loop and closed-loop (Figure 1). It can be observed that the color of the solution quickly changed from colorless to red, which indicates that compound 1 had closed-loop light under the action of ultraviolet light. Discoloration reaction. Then, the ring-closed compound 1 was irradiated with blue light at 493 nm, and the solution color was observed to change from red to colorless, indicating that the ring-closed compound 1 had a photochromic reaction of ring-opening under visible light.
结合实施例3和实施例4可知:关环化合物的杀虫效果更好。Combining Example 3 and Example 4 shows that the insecticidal effect of the ring-closure compound is better.
实施例5化合物1的耐疲劳性Example 5 Fatigue Resistance of Compound 1
耐疲劳性是基于化合物经历光致变色的呈色和消色之间循环次数的评价指标。光致变色反应总是伴随着化学键的改变,在此过程中,副反应的发生不可避免。这无疑会导致化合物的部分降解,降低化合物的耐疲劳度。二芳基乙烯化合物的耐疲劳性除了受到环境因素的影响外,其自身分子结构的差异也会造成其耐疲劳度的不同。在分子结构方面,芳基上取代基的类型会对其耐疲劳性造成很大的影响,而且非对称结构也可以提高化合物的耐疲劳性。Fatigue resistance is an evaluation index based on the number of cycles between coloration and decolorization of a compound undergoing photochromism. Photochromic reactions are always accompanied by changes in chemical bonds. In this process, the occurrence of side reactions is inevitable. This will undoubtedly lead to partial degradation of the compound and reduce the fatigue resistance of the compound. Apart from the environmental factors, the fatigue resistance of diarylethylene compounds is also affected by the differences in their molecular structure. In terms of molecular structure, the type of substituents on aryl groups will greatly affect its fatigue resistance, and asymmetric structures can also improve the fatigue resistance of compounds.
研究表明,二苯并噻吩全氟环戊烯类化合物普遍具有很高的耐疲劳度,在空气中的循环次数最高可以达到10 4以上。 Studies have shown that dibenzothiophene perfluorocyclopent-based compound has high general fatigue endurance, number of cycles in the air can be up to 104 or more.
当采用紫外光和可见光交替照射化合物1的乙腈溶液时,它表现出良好的光致变色性能。当用310nm紫外光照射时,化合物1的乙腈溶液由无色变为红色,并且在550nm附近处出现了新的特征吸收峰,这表明它形成了闭环体的化合物。而当大于493nm光照射时,溶液红色消失,闭环态的化合物发生开环反应变成开环态的化合物。When the acetonitrile solution of Compound 1 was irradiated with ultraviolet light and visible light alternately, it exhibited good photochromic properties. When irradiated with 310 nm ultraviolet light, the acetonitrile solution of Compound 1 changed from colorless to red, and a new characteristic absorption peak appeared near 550 nm, which indicates that it forms a closed-loop compound. When the light is larger than 493nm, the red color of the solution disappears, and the ring-opened compound undergoes a ring-opening reaction to become a ring-opened compound.
重复采用不同波长光照射的过程,结果如图2所示,整个成色和漂白过程可以重 复6次以上而未发生大的衰减,这表明化合物1具有良好的耐疲劳性。Repeating the process of irradiating with different wavelengths of light, the results are shown in Figure 2. The entire color formation and bleaching process can be repeated more than 6 times without large attenuation, which indicates that Compound 1 has good fatigue resistance.
实施例6含有本发明化合物的杀虫剂组合物的制备Example 6 Preparation of a Pesticide Composition Containing a Compound of the Invention
(a)油状悬浮液(a) Oily suspension
按比例准备以下组分:25%(重量百分比,下同)化合物1-7中任一种化合物;5%聚氧乙烯山梨醇六油酸酯;70%高级脂肪族烃油。将各组分在沙磨中一起研磨,直到固体颗粒降至约5微米以下为止。所得的粘稠悬浮液可直接使用,但也在水中乳化后使用。The following components were prepared in proportion: 25% (weight percent, the same below) of any one of compounds 1-7; 5% polyoxyethylene sorbitol hexaoleate; 70% higher aliphatic hydrocarbon oil. The components are ground together in a sand mill until the solid particles fall below about 5 microns. The obtained viscous suspension can be used directly, but it can also be used after emulsified in water.
(b)水悬浮液(b) Water suspension
按比例准备以下组分:25%化合物1-7中任一种化合物;3%水合硅镁土(hydrate attapulgit);10%木质素磺酸钙;0.5%磷酸二氢钠;61.5%水。将各组分在球磨机中一起研磨,直到固体颗粒降至约10微米以下为止。该水悬浮液可直接使用。The following components were prepared in proportion: 25% of any one of compounds 1-7; 3% hydrated attapulgit; 10% calcium lignosulfonate; 0.5% sodium dihydrogen phosphate; and 61.5% water. The components are ground together in a ball mill until the solid particles fall below about 10 microns. This aqueous suspension can be used directly.
(c)饵剂(c) Bait
按比例准备以下组分:0.1-10%化合物1-7中任一种化合物;80%小麦面粉;19.9-10%糖蜜。将这些组分完全混合,按需要形成饵形状。可食用饵可以分散到卫生害虫所侵染的场所,例如家居或工业场所,诸如厨房、医院或商店或户外区域,以通过口服摄入来防治害虫。Prepare the following components in proportion: 0.1-10% of any one of compounds 1-7; 80% wheat flour; 19.9-10% molasses. These components are thoroughly mixed to form a bait shape as required. Edible bait can be dispersed to places where sanitary pests infect, such as domestic or industrial places, such as kitchens, hospitals or shops or outdoor areas, to control the pests by oral ingestion.
本发明提及的所有文献都在本申请中引用作为参考,就如同每一篇文献被单独引用作为参考那样。此外应理解,在阅读了本发明的上述讲授内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。All documents mentioned in the present invention are incorporated by reference in this application, as if each document was individually incorporated by reference. In addition, it should be understood that after reading the above teaching content of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.

Claims (14)

  1. 具有式(A)所示结构的化合物、或所述化合物的光学异构体、顺反异构体或其盐:A compound having a structure represented by formula (A), or an optical isomer, cis-trans isomer of the compound, or a salt thereof:
    Figure PCTCN2019093093-appb-100001
    Figure PCTCN2019093093-appb-100001
    式(A)中:In formula (A):
    R 1,R 2各自独立地为H、取代或未取代的C 1-6烷基、烯丙基、苄基、取代或未取代的C 1-4烷氧基-C 1-6烷基、取代或未取代的C 1-6烷基-羰基、取代或未取代的C 1-4烷氧基-羰基或苯氧羰基;或者R 1和R 2共同构成-CH 2-CH 2-或-CH 2-CH 2-CH 2-; R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
    各个R 3分别独立地为氢、取代或未取代的C 1-4烷基、卤原子、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
    R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟、C 1-4烷基、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环;或R 4、R 5、R 8和R 9中的一种和R 6或R 7的结合构成取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
    各个R 10分别独立地为C 1-4烷基或C 1-4烷氧基; Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy;
    Z选自S、O或NH;Z is selected from S, O or NH;
    其中,上述的取代是指氢原子被选自下组的基团所取代:卤原子、C 1-6烷基或卤代C 1-6烷基、C 1-6烷氧基或卤代C 1-6烷氧基、C 2-6烯基、C 2-6炔基、卤代的C 2-6烯基、卤代的C 2-6炔基、C 1-4烷氧基-C 1-6烷基、C 1-6烷氧基-羰基、C 2-6炔基-羰基、C 2-6烯基-羰基。 Wherein, the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group. 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkenyl, halogenated C 2-6 alkynyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-carbonyl, C 2-6 alkynyl-carbonyl, C 2-6 alkenyl-carbonyl.
  2. 如权利要求1所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐,其特征在于,R 1,R 2各自独立地为氢或C 1-4烷基。 The compound according to claim 1, or an optical isomer, cis-trans isomer, or a salt thereof, wherein R 1 and R 2 are each independently hydrogen or C 1-4 alkyl.
  3. 如权利要求1所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐,其特征在于,各个R 3分别独立地为氢、C 1-3烷基或卤原子。 The compound according to claim 1, or an optical isomer, cis-trans isomer, or a salt thereof, wherein each R 3 is independently hydrogen, a C 1-3 alkyl group, or a halogen atom. .
  4. 如权利要求1所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐,其特征在于,R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟或C 1-4烷基。 The compound according to claim 1, or an optical isomer, cis-trans isomer or a salt thereof, wherein R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are respectively Independently is hydrogen, fluorine or C 1-4 alkyl.
  5. 如权利要求1所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐, 其特征在于,各个R 10分别独立地为C 1-2烷基或C 1-2烷氧基。 The compound according to claim 1, or an optical isomer, cis-trans isomer or a salt thereof, wherein each R 10 is independently a C 1-2 alkyl group or a C 1-2 Alkoxy.
  6. 如权利要求1所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐,其特征在于,Z为S。The compound according to claim 1, wherein Z is S, or an optical isomer, cis-trans isomer of the compound, or a salt thereof.
  7. 具有式(B)所示结构的化合物、或所述化合物的光学异构体、顺反异构体或其盐:A compound having a structure represented by formula (B), or an optical isomer, cis-trans isomer of the compound, or a salt thereof:
    Figure PCTCN2019093093-appb-100002
    Figure PCTCN2019093093-appb-100002
    式(B)中:In formula (B):
    R 1,R 2各自独立地为H、取代或未取代的C 1-6烷基、烯丙基、苄基、取代或未取代的C 1-4烷氧基-C 1-6烷基、取代或未取代的C 1-6烷基-羰基、取代或未取代的C 1-4烷氧基-羰基或苯氧羰基;或者R 1和R 2共同构成-CH 2-CH 2-或-CH 2-CH 2-CH 2-; R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
    各个R 3分别独立地为氢、取代或未取代的C 1-4烷基、卤原子、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
    R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟、C 1-4烷基、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环;或R 4、R 5、R 8和R 9中的一种和R 6或R 7的结合构成取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
    各个R 10分别独立地为C 1-4烷基或C 1-4烷氧基; Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy;
    Z选自S、O或NH;Z is selected from S, O or NH;
    其中,上述的取代是指氢原子被选自下组的基团所取代:卤原子、C 1-6烷基或卤代C 1-6烷基、C 1-6烷氧基或卤代C 1-6烷氧基、C 2-6烯基、C 2-6炔基、卤代的C 2-6烯基、卤代的C 2-6炔基、C 1-4烷氧基-C 1-6烷基、C 1-6烷氧基-羰基、C 2-6炔基-羰基、C 2-6烯基-羰基。 Wherein, the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group. 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkenyl, halogenated C 2-6 alkynyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-carbonyl, C 2-6 alkynyl-carbonyl, C 2-6 alkenyl-carbonyl.
  8. 一种杀虫剂组合物,其包含0.001-99.99重量%的成分(a)和成分(b);其中,An insecticide composition comprising 0.001-99.99% by weight of component (a) and component (b); wherein,
    成分(a)为权利要求1-6中任一项所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;和/或权利要求7所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;Component (a) is a compound according to any one of claims 1 to 6, or an optical isomer, cis-trans isomer or a salt thereof; and / or a compound according to claim 7, or Optical isomers, cis-trans isomers, or salts thereof of the compounds;
    成分(b)为农药学上可接受的载体和/或赋形剂。Ingredient (b) is a pesticidely acceptable carrier and / or excipient.
  9. 如权利要求8所述的杀虫剂组合物,其特征在于,所述杀虫剂组合物用于杀灭或预防选自如下的害虫:鞘翅目、鳞翅目、半翅目、直翅目、等翅目、或双翅目昆虫。The insecticide composition according to claim 8, wherein the insecticide composition is used to kill or prevent a pest selected from the group consisting of Coleoptera, Lepidoptera, Hemiptera, Orthoptera , Isoptera, or Diptera insects.
  10. 一种杀虫和/或防虫方法,所述方法包括将如下一种或多种施加于遭受或可能 遭受虫害的植物体、其周围的土壤或环境中:An insecticidal and / or pest control method comprising applying one or more of the following to a plant body that has suffered or is likely to be exposed to pests, the surrounding soil, or the environment:
    权利要求1-6中任一项所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;The compound according to any one of claims 1-6, or an optical isomer, a cis-trans isomer of the compound, or a salt thereof;
    权利要求7所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;The compound according to claim 7, or an optical isomer, cis-trans isomer of the compound, or a salt thereof;
    权利要求8所述的杀虫剂组合物;The insecticide composition of claim 8;
    并任选地用波长为310-380nm的光照射该植物体、其周围的土壤或环境。The plant body, the surrounding soil, or the environment is optionally illuminated with light having a wavelength of 310-380 nm.
  11. 权利要求1-6中任一项所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;权利要求7所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;或权利要求8所述的杀虫剂组合物,在制备杀虫剂组合物中的用途。The compound according to any one of claims 1 to 6, or an optical isomer, cis-trans isomer, or a salt thereof; the compound according to claim 7, or an optical isomer of the compound , A cis-trans isomer or a salt thereof; or the use of the insecticide composition according to claim 8 in the preparation of an insecticide composition.
  12. 如权利要求1-6任一项所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐的用途,其特征在于,所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐在310-380nm波长的光照射后生成如权利要求7所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;The compound according to any one of claims 1 to 6, or the use of an optical isomer, cis-trans isomer or a salt of the compound, wherein the compound, or the optical Isomers, cis-trans isomers, or salts thereof after irradiation with light at a wavelength of 310-380 nm generate the compound according to claim 7, or optical isomers, cis-trans isomers, or salts thereof;
    Figure PCTCN2019093093-appb-100003
    Figure PCTCN2019093093-appb-100003
    各式中:Of the various types:
    R 1,R 2各自独立地为H、取代或未取代的C 1-6烷基、烯丙基、苄基、取代或未取代的C 1-4烷氧基-C 1-6烷基、取代或未取代的C 1-6烷基-羰基、取代或未取代的C 1-4烷氧基-羰基或苯氧羰基;或者R 1和R 2共同构成-CH 2-CH 2-或-CH 2-CH 2-CH 2-; R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
    各个R 3分别独立地为氢、取代或未取代的C 1-4烷基、卤原子、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
    R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟、C 1-4烷基、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环;或R 4、R 5、R 8和R 9中的一种和R 6或R 7的结合构成取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
    各个R 10分别独立地为C 1-4烷基或C 1-4烷氧基; Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy;
    Z选自S、O或NH;Z is selected from S, O or NH;
    其中,上述的取代是指氢原子被选自下组的基团所取代:卤原子、C 1-6烷基或卤代C 1-6烷基、C 1-6烷氧基或卤代C 1-6烷氧基、C 2-6烯基、C 2-6炔基、卤代的C 2-6烯基、卤代的C 2-6炔基、C 1-4烷氧基-C 1-6烷基、C 1-6烷氧基-羰基、C 2-6炔基-羰基、C 2-6烯基-羰基。 Wherein, the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group. 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkenyl, halogenated C 2-6 alkynyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-carbonyl, C 2-6 alkynyl-carbonyl, C 2-6 alkenyl-carbonyl.
  13. 如权利要求7所述的化合物,或所述化合物的光学异构体、顺反异构体或其盐 的用途,其特征在于,所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐在大于493nm(优选为493-760nm)波长的光照下生成如权利要求1-6任一项所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐;The compound according to claim 7, or the use of an optical isomer, cis-trans isomer or a salt thereof, wherein the compound, or the optical isomer, cis The anti-isomer or salt thereof generates a compound according to any one of claims 1-6, or an optical isomer, cis-trans isomer of the compound under light having a wavelength of more than 493 nm (preferably 493-760 nm). Body or salt thereof;
    Figure PCTCN2019093093-appb-100004
    Figure PCTCN2019093093-appb-100004
    各式中:Of the various types:
    R 1,R 2各自独立地为H、取代或未取代的C 1-6烷基、烯丙基、苄基、取代或未取代的C 1-4烷氧基-C 1-6烷基、取代或未取代的C 1-6烷基-羰基、取代或未取代的C 1-4烷氧基-羰基或苯氧羰基;或者R 1和R 2共同构成-CH 2-CH 2-或-CH 2-CH 2-CH 2-; R 1 and R 2 are each independently H, substituted or unsubstituted C 1-6 alkyl, allyl, benzyl, substituted or unsubstituted C 1-4 alkoxy-C 1-6 alkyl, Substituted or unsubstituted C 1-6 alkyl-carbonyl, substituted or unsubstituted C 1-4 alkoxy-carbonyl or phenoxycarbonyl; or R 1 and R 2 together form -CH 2 -CH 2 -or- CH 2 -CH 2 -CH 2- ;
    各个R 3分别独立地为氢、取代或未取代的C 1-4烷基、卤原子、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; Each R 3 is independently hydrogen, a substituted or unsubstituted C 1-4 alkyl group, a halogen atom, a substituted or unsubstituted 6 to 10 membered aromatic ring group, or a substituted or unsubstituted 5 to 6 membered heterocyclic ring;
    R 4、R 5、R 6、R 7、R 8和R 9分别独立地为氢、氟、C 1-4烷基、取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环;或R 4、R 5、R 8和R 9中的一种和R 6或R 7的结合构成取代或未取代的6~10元芳环基、或取代或未取代的5~6元杂环; R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are each independently hydrogen, fluorine, C 1-4 alkyl, substituted or unsubstituted 6 to 10 membered aromatic ring group, or substituted or unsubstituted A 5- to 6-membered heterocyclic ring; or a combination of one of R 4 , R 5 , R 8 and R 9 and R 6 or R 7 constitutes a substituted or unsubstituted 6 to 10-membered aromatic ring group, or a substituted or unsubstituted Substituted 5-6 membered heterocyclic ring;
    各个R 10分别独立地为C 1-4烷基或C 1-4烷氧基; Each R 10 is independently C 1-4 alkyl or C 1-4 alkoxy;
    Z选自S、O或NH;Z is selected from S, O or NH;
    其中,上述的取代是指氢原子被选自下组的基团所取代:卤原子、C 1-6烷基或卤代C 1-6烷基、C 1-6烷氧基或卤代C 1-6烷氧基、C 2-6烯基、C 2-6炔基、卤代的C 2-6烯基、卤代的C 2-6炔基、C 1-4烷氧基-C 1-6烷基、C 1-6烷氧基-羰基、C 2-6炔基-羰基、C 2-6烯基-羰基。 Wherein, the above-mentioned substitution means that the hydrogen atom is replaced by a group selected from the group consisting of a halogen atom, a C 1-6 alkyl group or a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, or a halogenated C group. 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkynyl, halogenated C 2-6 alkenyl, halogenated C 2-6 alkynyl, C 1-4 alkoxy-C 1-6 alkyl, C 1-6 alkoxy-carbonyl, C 2-6 alkynyl-carbonyl, C 2-6 alkenyl-carbonyl.
  14. 如权利要求1-6任一项所述的化合物、或所述化合物的光学异构体、顺反异构体或其盐的制备方法,其特征在于,The method for preparing a compound according to any one of claims 1-6, or an optical isomer, a cis-trans isomer of the compound, or a salt thereof, characterized in that:
    (a)当R1与R2相同时,所述方法包括步骤:在惰性溶剂中,将式(1g)化合物与式01或01’化合物反应,从而得到式(A)化合物;(a) When R1 is the same as R2, the method includes the step of: reacting a compound of formula (1g) with a compound of formula 01 or 01 'in an inert solvent to obtain a compound of formula (A);
    Figure PCTCN2019093093-appb-100005
    Figure PCTCN2019093093-appb-100005
    上述各式中,各个基团的定义同前且R1与R2相同;In the above formulas, the definition of each group is the same as above and R1 and R2 are the same;
    or
    (b)当R1与R2不相同时,所述方法包括步骤:在惰性溶剂中,将式(1g)化合物与式01化合物反应,从而得到式(1h)化合物;和在惰性溶剂中,将式(1h)化合物与式01’化合物反应,从而得到式(A)化合物;(b) when R1 and R2 are different, the method includes the steps of: reacting a compound of formula (1g) with a compound of formula 01 in an inert solvent to obtain a compound of formula (1h); and in an inert solvent, (1h) reacting a compound with a compound of formula 01 'to obtain a compound of formula (A);
    Figure PCTCN2019093093-appb-100006
    Figure PCTCN2019093093-appb-100006
    上述各式中,各个基团的定义同前且R1与R2不相同;In the above formulas, the definition of each group is the same as above and R1 and R2 are different;
    or
    (c)当R1与R2不相同时,所述方法包括步骤:在惰性溶剂中,将式(1g)化合物与式01化合物和式01’化合物反应,从而得到式(A)化合物;(c) When R1 and R2 are different, the method includes the step of: reacting a compound of formula (1g) with a compound of formula 01 and a compound of formula 01 'in an inert solvent to obtain a compound of formula (A);
    Figure PCTCN2019093093-appb-100007
    Figure PCTCN2019093093-appb-100007
    上述各式中,各个基团的定义同前且R1与R2不相同。In the above formulae, the definition of each group is the same as above and R1 and R2 are different.
PCT/CN2019/093093 2018-06-29 2019-06-26 Diarylethene compound and preparation and use thereof WO2020001494A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810694476.8A CN110655512B (en) 2018-06-29 2018-06-29 Diarylethene compounds, preparation and use thereof
CN201810694476.8 2018-06-29

Publications (1)

Publication Number Publication Date
WO2020001494A1 true WO2020001494A1 (en) 2020-01-02

Family

ID=68985853

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/093093 WO2020001494A1 (en) 2018-06-29 2019-06-26 Diarylethene compound and preparation and use thereof

Country Status (2)

Country Link
CN (1) CN110655512B (en)
WO (1) WO2020001494A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114907334A (en) * 2021-02-10 2022-08-16 中国科学院福建物质结构研究所 Dithiophene ethylene lactone compound and preparation and light regulation and control methods thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102633722A (en) * 2012-03-20 2012-08-15 金坛市凌云动物保健品有限公司 Fipronil preparation method
CN106397419A (en) * 2016-09-09 2017-02-15 华东理工大学 Diarylethene type photochromic insecticidal compound and preparation method and purpose thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100501829B1 (en) * 2001-07-30 2005-07-20 한국화학연구원 Diarylethene derivatives and the photochromic thin film using of them
CN100427479C (en) * 2004-08-30 2008-10-22 江西科技师范学院 Photochromic perfluoro cyclopentene diaryl ethylene schiff base compound, and its preparing method and use
MX2014013430A (en) * 2012-05-04 2015-04-14 Basf Se Substituted pyrazole-containing compounds and their use as pesticides.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102633722A (en) * 2012-03-20 2012-08-15 金坛市凌云动物保健品有限公司 Fipronil preparation method
CN106397419A (en) * 2016-09-09 2017-02-15 华东理工大学 Diarylethene type photochromic insecticidal compound and preparation method and purpose thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VENKATAKRISHNARAO DASARI ET AL: "Photonic Microrods Composed of Photoswitchable Molecules: Erasable Heterostructure Waveguides for Tunable Optical Modula- tion", ADVANCED OPTICAL MATERIALS, vol. 3, no. 8, 2 April 2015 (2015-04-02), pages 1035 - 1040, XP055669672, ISSN: 2195-1071, DOI: 10.1002/adom.201500106 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114907334A (en) * 2021-02-10 2022-08-16 中国科学院福建物质结构研究所 Dithiophene ethylene lactone compound and preparation and light regulation and control methods thereof
CN114907334B (en) * 2021-02-10 2023-09-08 中国科学院福建物质结构研究所 Dithiophene vinyl lactone compound and preparation and light control method thereof

Also Published As

Publication number Publication date
CN110655512A (en) 2020-01-07
CN110655512B (en) 2023-02-28

Similar Documents

Publication Publication Date Title
CN108003162B (en) Condensed heterocyclic compouds and its application
HUE027086T2 (en) Tetrazol-substituted anthranilic acid amides as pesticides
TW201022260A (en) Heterocyclic compounds as pesticides
CN103524422A (en) Benzimidazole derivative, and preparation method and purpose thereof
CN108129481B (en) Condensed heterocyclic compouds and its application of the one kind containing pyrazole ring
WO2020156512A1 (en) Aromatic (hetero)cyclic ether compound having insecticidal activity, preparation method therefor, and application thereof
JP2010532750A (en) Heterocyclically substituted heterocyclic carboxylic acid derivatives
TW200406152A (en) 4-(3,3-Dihalo-allyloxy) phenol derivatives having pesticidal properties
CN111253400B (en) Halogenated pyrazole matrine derivative with insecticidal activity and preparation method and application thereof
CN114605324A (en) Isoxazoline substituted benzamide derivative and preparation method and application thereof
WO2020001494A1 (en) Diarylethene compound and preparation and use thereof
CN110551148B (en) Compound containing silicon acyl acetonitrile, preparation method and application thereof
CN106397419B (en) A kind of diarylethene can photochromic Pesticidal compound and its preparation method and application
CN112745269A (en) Phenyl isoxazoline compound and application thereof
ES2260247T3 (en) COMPOUNDS OF 2- (3,5-DISUSTITUTED-4-PIRIDIL) -4- (TIENIL OR TIAZOLIL OR ARILFENIL) -1,3-OXAZOLINE.
CN113461630B (en) Nootkatone thioether derivative containing 1,3, 4-oxadiazole ring, and preparation method and application thereof
CN111205223B (en) Quinoline derivatives, preparation method and application thereof
CN114621280A (en) Silicon acrylonitrile compound and preparation method and application thereof
CN109988149B (en) Pyrazole amide compound with insecticidal activity and application thereof
CN110452167B (en) Quinoline derivatives, preparation method and application thereof
CN112745297A (en) Pyrimidine-containing piperidine amine compound and preparation method and application thereof
CN117534677B (en) Imine-containing tricyclic fused heterocyclic compound and application thereof
CN109320505B (en) Preparation and application of halogenated butenolide compound with insecticidal activity
JPS63126806A (en) Agricultural and horticultural insecticidal composition
CN110272452B (en) Quinoline derivatives, preparation method and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19825420

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19825420

Country of ref document: EP

Kind code of ref document: A1